{
  "name" : "moscow.sci-hub.se_5104_2ad3abf38ed0e6906bb03fc054a39d89_abdel-rahman2016.pdf",
  "metadata" : {
    "source" : "META",
    "title" : "Some new nano-sized Cr(III), Fe(II), Co(II), and Ni(II) incorporating 2-((E)-(pyridine-2-ylimino)methyl)napthalen-1-ol ligand: Structural characterization, electrochemical, antioxidant, antimicrobial, antiviral assessment and DNA interaction",
    "authors" : [ "Laila H. Abdel-Rahman", "Ahmed M. Abu-Dief", "Emad F. Newair", "Samar Kamel Hamdan" ],
    "emails" : [ "lailakenawy@hotmail.com" ],
    "sections" : [ {
      "heading" : null,
      "text" : "AC C\nEP TE\nD M\nAN U\nSC R\nTo estimate the biological preference of synthetic small drugs towards DNA\ntarget, new metal based chemotherapeutic agents of nano-sized Cr(III), Fe(II), Co(II) and Ni(II) Schiff base complexes having N,N,O donor system were synthesized and thoroughly characterized by physic-chemical techniques. The redox behavior of the Cr(III), Fe(II) and Co(II) complex was investigated by electrochemical method using cyclic voltammetry. IR results proven that the tridentate binding of Schiff base ligand with metal center during complexation and reflects the proposed structure. Magnetic and spectroscopic data give support to octahedral geometry for Cr(III) and Fe(II) complexes and tetrahedral geometry for Ni(II) and Co(II) complexes. The activation thermodynamic parameters, such as, E * , ΔH * , ΔS * and ΔG * are calculated using Coats– Redfern method by analyzing the TGA data. The particle size of the investigated metal complexes was estimated by TEM. In addition to, the interaction of the nanosized metal complexes with CT-DNA was estimated by electronic absorption, viscosity and gel electrophoresis. These techniques revealed that the complexes could bind to CT-DNA through intercalation mode. Moreover, the in vitro cytotoxic and antiviral activities of the nanosized complexes were checked against Herpes Simplex virus and Tobacco Mosaic viruses. Moreover, investigation of antioxidant activities of the new nanosized compounds was done by ABTS assay. Among the compounds tested, Fe(II) complex showed the strongest potent radical scavenging activity with percent of 58.60 %. Furthermore, the antimicrobial bustle of the prepared compounds were screened different types of bacteria and fungi and the results show that all metal complexes have superior activity than free ligand.\nKeywords: Nano-sized; cyclic voltammetry, antioxidant activity; Antimicrobial activity; Antiviral activity, DNA interaction\nAC C\nEP TE\nD M\nAN U\nSC R\nIP T"
    }, {
      "heading" : "ACCEPTED MANUSCRIPT",
      "text" : "1. Introduction\nMetal complexes of oxygen and nitrogen containing Schiff bases have been the\nsubject of current and growing interest because it possesses wide range of pharmacological activities [1-5]. For example, Pyridines are common but vital heterocyclic compounds in organic synthesis, especially as synthetic intermediates and agrochemicals. For example, pyridine derivatives, such as (aromatic) alkoxyl pyridine compounds, amino pyridine, and its derivatives, substituted fused pyridine compounds, have already been applied in widely the fields of agrochemical products [6]. Moreover, pyridine derivatives play individual role in anthelminthic, bacteriocide, acaricide, and phytocide [7]. For these biological effects we choose the pyridine derivative ligand as a starting material. Schiff bases as versatile organic blockers have recently attracted great attention due to their varied dentcities, preparative accessibilities and structural varieties. DNA plays an important role in the life process since it includes all the genetic information for the cellular function. However, DNA is the primary intracellular target of anticancer drugs, damaged under variety of conditions like interactions with some small molecules, which cause damage of DNA in cancer cells, blocking the division of cancer cells and resulting in cell death. Metal complexes like cobalt, nickel, copper, and zinc with Schiff base ligands have exhibited excellent binding and cleavage activities [8–10]. On the other hand, an increasing interest in antioxidant, particularly in those intended to prevent the mischievous effects in the human body caused by the free radicals is an attracting one. The free radicals (OH . , O2 .- , etc.) are also believed to be a connected with carcinogenesis, mutagenesis, arthritis, diabetes, inflammation, cancer, and genotoxicity due to the oxidative stress which appear as a result of imbalance between free radical generations [11, 12]. Free oxygen radicals may protect against attack of the virus and can produce tissue damage during this protection by trig-gering inflammation [13]. Free radicals react with adjacent entities and can injury molecules, cells, tissues, DNA and finally the whole organs. The body has evolved mechanisms for neutralizing free radicals, involved in enzymes like superoxide dismutase, catalase and glutathione peroxidase. Oxidative stress is implicated in the pathogenesis of atherosclerosis, and of viral infections caused by Sendai virus, influenza and HIV. Infection with Herpes simplex virus (HSV) causes a wide range of diseases, ranging from genital disease to encephalitis. The virus infects Patients with immune deficiency and newborns [14]. After primary infection, HSV tends to persist in the neurons of the\nAC C\nEP TE\nD M\nAN U\nSC R\nIP T"
    }, {
      "heading" : "ACCEPTED MANUSCRIPT",
      "text" : "ganglia. Reactivation of latent HSV, which is very prevalent during immunity deficiency, causes periodic herpetic infections [15]. In plants, virus infections cause a variety of detrimental effects and often leave plants more susceptible to damage by other pathogens and pests. Annually, viruses and viroids cause significant and costly crop losses and which are responsible for a wide variety of plant diseases. Some viral diseases, for example, rice tungro, African cassavamosaic, and tospoviruses, are evaluated to cause casualties losses in excess of AUD$1 billion worldwide [16]. The tobacco mosaic virus (TMV) infects commercial plants including tobacco and related plants such as tomato and pepper. While not fatal, TMV affects the growth and productivity of these plants. Bearing the above facts in mind, and as a part of our continuing research, herein the preparation of tridentate heterocyclic Schiff base ligand (npap) and its complexes has been reported. In order to investigate the coordination mode of ligand, the complexes of Cr(III), Fe(II), Co(II) and Ni(II) have been characterized by UV–Vis, IR, TGA and cyclic voltammetry. Moreover, the antimicrobial, DNA binding, antioxidant, cytotoxicity and antiviral activities of the complexes have been also investigated.\n2. Experimental protocol\n2.1. Materials\nAll the used chemicals and solvents in this study were of reagent grade and\nused as received without purification such as transition metal salts [CrCl3.6H2O, (NH4)2Fe(SO4)2·6H2O, Ni(NO3)2.6H2O and Co(NO3)2.6H2O] and organic compounds [2-hydroxy-1-napthaldehyde (np), 2-aminopyridine (ap)]. Calf thymus DNA (CT-DNA) and Tris [hydroxymethyl]-amino methane (Tris) were obtained from Sigma– Aldrich Chemie. Spectroscopic grade ethanol, N, N -̀dimethylsulfoxide (DMF), N, N -̀ dimethylsulfoxide and HCl products were used without distillation. 6-Hydroxy-2, 5, 7, 8-tetramethylchromane-2-carboxylic acid (Trolox), 2′-azinobis-3-ethylbenzothiazoline6-sulfonic acid (ABTS), were purchased from Sigma Chemical Co.The Vero cell line was maintained in RPMI 1640 (Gibco, Tunisia) supplemented to fetal bovine serum (10%, v/v), L-Glutamin (2 mM), streptomycin (100 μg/mL) and penicillin (100 U/mL),. Cells were incubated in a 5% CO2 humidified atmosphere. Coxsakievirus B3 Nancy strain was propagated in Vero cells (kindly provided by Pr. Bruno Pozzetto, Laboratory of Bacteriology-Virology, Saint-Etienne, France) was propagated in Vero cells.\nAC C\nEP TE\nD M\nAN U\nSC R\nIP T"
    }, {
      "heading" : "ACCEPTED MANUSCRIPT",
      "text" : ""
    }, {
      "heading" : "2.2. Preparation of Schiff base ligand",
      "text" : "The npap Schiff base ligand was synthesized by refluxing equimolar\nquantities (5 mmol) of 2-aminopyridine (0.47 g, 5 cm 3 ) and 2-hydroxy-1-napthaldehyde (0.86 g, 10 cm 3 ) in ethanol (cf. Scheme 1). The mixture was stirred for 1 h under reflux at 70 o C and the reaction was monitored through TLC. After completion of reaction, the solution was gradually evaporated to quarter of its original volume and then left to cool. On standing, the yellow crystals were separated by vacuum filtration, washed several times with ethanol. The yellow crystal of npap ligand was recrystallized from ethanol and finally dried in vacuo over anhydrous CaCl2. For npap, Yellow crystals; m.p.: 170 °C; yield (88 %). 1 H NMR (400 MHz, DMSOd6): δ = 6.86 (d, 1H, ArH naphthyl, 3 J = 9.3 Hz), 7.36-7.30 (m, 2H, ArH naphthyl), 7.54 (t, 1H, ArH naphthyl, 3 J = 8.1, 7.3 Hz), 7.63 (d, 1H, ArH naphthyl, 3 J = 8.0 Hz), 7.74 (d, 1H, ArH naphthyl, 3 J = 7.7 Hz), 7.90 (d, m-pyH, 1H, 3 J = 9.4 Hz), 7.95 (dt, 1H, p-pyH, 4 J = 1.4, 1.7 Hz, 3 J = 7.4, 7.7 Hz), 8.26 (d, 1H, m-pyH, 3 J = 8.3 Hz), 9.85 (s, 1H, CH=N, 4 J = 0.7 Hz, 3 J = 4.5 Hz), 15.19 ppm (s, 1H, OH, 3 J = 8.0 Hz);\n13\nC NMR (100 MHz and DEPT135, DMSO-d6): δ = 108.6 (Cq, C-CH=N), 115.8 (CH), 120.1 (CH), 122.0 (CH), 124.3 (CH), 124.4 (CH), 127.0 (Cq, naphthyl), 129.1 (CH), 129.6 (CH), 134.1 (Cq, -OH), 139.3 (CH m-py), 139.5 (CH m-py), 149.4 (CH p-py), 151.5 (CH, o-py), 153.6 (Cq-py), 176.9 ppm (CH, CH=N). FT-IR (v, cm -1 ) (KBr Disc): 3426 (s), 3030 (w), 1630 (vs), 1585 (sh), 1315 (m).\n2.2. Preparation of Schiff base metal complexes\nThe prepared metal complexes were synthesized according to the following :\nAn ethanolic solution of CrCl3.6H2O, Co(NO3)2.6H2O and Ni(NO3)2.6H2O (1 mmol, 4 cm 3 ) was added drop wise to the solution of prepared npap Schiff base ligand (1 mmol, 10 cm 3 ) and stirred for 3h. The resulting solutions were stirred magnetically for 3 h at 25 o C [2-5, 17, 18, 19]. Then the precipitate obtained was filtered, washed with ethanol, and then dried in vacuo over anhydrous CaCl2. Fe(II) complex was obtained by treating ethanolic solution of npap ligand (2 mmol, 15 cm 3 ) with aqueous ethanolic solution (5ml) of (NH4)2Fe(SO4)2·6H2O (1 mmol, 0.39 g). A few drops of glacial acetic acid [20] were added to obviate the oxidation of Fe(II). The resulting solution was stirred magnetically for 8 h under nitrogen at 25 o C. The resulting solution was stirred magnetically. Then the obtained solid product was filtered, washed with ethanol, and then dried in vacuo over anhydrous CaCl2 [2-5, 21]. The analytical and physical data of the ligand (npap) and the metal complexes are presented in Table 2.\nAC C\nEP TE\nD M\nAN U\nSC R\nIP T"
    }, {
      "heading" : "ACCEPTED MANUSCRIPT",
      "text" : "For npapCr complex, a brown solid was obtained; m.p.: 288 °C; yield (77%). FT-IR(v, cm -1 ) (KBr Disc): 3467 (b), 3048 (w), 1620 (vs), 1568 (sh), 1265 (m), 615 (w), 482 (w). For npapFe complex, a dark brown solid was obtained; m.p.: > 300 °C; yield (78%). FT-IR(v, cm -1 ) (KBr Disc): 3434 (b), 3050 (w), 1610 (vs), 1577 (sh), 1250 (m), 549 (w), 456 (w). For npapCo complex, a orange solid was obtained; m.p.: > 300 °C; yield (85%). FT-IR(v, cm -1 ) (KBr Disc): 3441 (b), 3039 (w), 1603 (s), 1574 (sh), 1290 (m), 518 (w), 453 (w). For npapNi complex, a bright green solid was obtained; m.p.: > 300 °C; yield (84%). FT-IR(v, cm -1 ) (KBr Disc): 3450 (b), 3064 (w), 1615 (vs), 1570 (sh), 1290 (m), 518 (w), 453 (w).\n2.3. Instruments\nSingle crystal X-ray structure of npap compound was recorded on a Bruker-\nNonius FR590 X-ray generator with a molybdenum sealed tube. NMR spectra of the ligand were measured on multinuclear FT-NMR spectrometer Bruker ARx 400 at 400.1 ( 1 H) and 100.6 ( 13 C) MHz using deuterated N, N` - dimethylsulfoxide (DMSO-d6). A Perkin-Elmer 240c Elemental analyzer was used to micro-analytical data (C, H and N). Molar Conductivities of the prepared metal complexes were determined in N, N -̀ dimethylformamide (DMF ~ 1×10 -3 M) at room temperature using Jenway conductivity meter model 4320. Magnetic measurements of complexes were determined on Gouy's balance, the diamagnetic correction were made by Pascal's contents and Hg[Co(SCN)4] as a calibrant. The FT-IR spectra of the compounds were recorded on Shimadzu FTIR 8101 spectrophotometer using KBr discs. Electronic spectra for Schiff base ligand and its complexes were recorded on Jasco P- 530 UV-Visible spectrophotometer model T+80 using 10 mm matched quartz cells and data were reported in λmax/nm. TGA analysis was recorded on a Shimaduz cooperation 60H analyzer under a dynamic flow of nitrogen atmosphere (40 ml / min) and heating rate 10 o C /min from ambient temperature to 750 o C. The values of absorbance of 10 -3 M of each complex were measured at different pH values. pH values were adjusted using a series of Britton universal buffer [22]. A HANNA 211 pH meter at 298 k equipped with a CL-51B combined electrode was used for pH measurements, calibrated against standard buffers (pH 4.02 and 9.18) before measurements. The electrochemical experiments of the complexes were investigated using an Autolab PGSTAT128N Potentiostat/Galvanostat\nAC C\nEP TE\nD M\nAN U\nSC R\nIP T"
    }, {
      "heading" : "ACCEPTED MANUSCRIPT",
      "text" : "(Metrohm Autolab B.V., Utrecht, The Netherlands) electrochemical analyzer operated via NOVA software (Metrohm Autolab B.V., Utrecht, The Netherlands). A conventional three-electrode electrolytic cell was employed, in which GCE was employed as a working electrode, glassy carbon electrode (3mm). A platinum electrode and a silversilver chloride electrode (Ag/AgCl 3.5 M) were used as the counter and reference electrodes, respectively. The particle size of metal complexes was determined using transmission electron microscopy TEM-2100, with an accelerating voltage of 200 kV. Particle size distribution of the prepared metal complexes was determined using image J Lanucher, broken-symmetry software, version (1.4.3.6.7). Viscosity measurements were performed by using Ostwald viscometer immersed in a thermo stated water bath maintained at 25 o C. Gel electrophoresis was visualized under UV a transilluminator and photographed with a Panasonic DMC-LZ5 Lumix Digital Camera. Antimicrobial screening was carried by using agar well diffusion. The viability of the infected and noninfected cells was evaluated according to the absorbance values of formazan using the MTT inclusion assay."
    }, {
      "heading" : "2.4. X- ray Crystallography",
      "text" : "The suitable crystals of the prepared ligand for X-ray analysis were obtained by\nrecrystallization from ethanol by slow evaporation. Diffraction data for the prepared npap Schiff base ligand was collected on Bruker-Nonius Kappa CCD at 293 K, equipped with a CCD detector. Experimental data, methods and the procedures used to explain the structure and other related parameters are shown in Table 1(a, b). The structure was solved by using the program(s): SHELXS86 [23]; program(s) used to refine structure: CRYSTALS [24]. Molecular graphics: CAMERON [25]; software used to prepare material for publication."
    }, {
      "heading" : "2.5. Magnetic moment measurements",
      "text" : "The magnetic susceptibility measurements supply information to support the\nelectronic structure of the investigated complexes. Magnetic susceptibility was calculated according to the following relation [2, 3, 4, 5, 26- 28]:\nTMeff '83.2  \n ..' corrdiamagMM  \nWhere µeff, is the magnetic moment (in Bohnr Magneton) B.M., 'M: molar magnetic susceptibility,T is the absolute temperature (K), M after correction.\n(1)\n(2)\nAC C\nEP TE\nD M\nAN U\nSC R\nIP T"
    }, {
      "heading" : "ACCEPTED MANUSCRIPT",
      "text" : ""
    }, {
      "heading" : "2.6. Evaluation of the Stiochmetry of the Schiff base ligand complexes",
      "text" : "Continuous variation methods [2, 3] and molar ratio [4, 5] were used to study\nthe equilibria in solutions and to determine M: L ratio as shown in Fig. 3 and 4"
    }, {
      "heading" : "2.7. Evaluation of the apparent formation constants of the synthesized complexes",
      "text" : "The apparent formation constants (Kf) of the synthesized complexes formed in\nsolution were determined from spectrophotometric measurements using the continuous variation method [2, 3, 4, 5, 29- 31], according to the following relations. The obtained Kf values (c.f Table 4) indicate the stability of these complexes.\nFor npapFe complex\n3\nm\n2\nm\n) A\nA(14C K\nA A\n  f\nFor npapCr, npapCu and npapNi complexes\nC 2\n) mA\nA(1\nmA A\nf K\n\n\nWhere, A is the arbitrary chosen absorbance values on either side of the absorbance mountain col (pass), C is the initial concentration of the metal, and Am is the absorbance at the maximum formation of the complex."
    }, {
      "heading" : "2.8. Kinetic studies for the prepared complexes",
      "text" : "The decomposition and thermal dehydration of the mentioned complexes were\nstudied kinetically using the integral method by applying the Coats–Redfern method. The thermodynamic activation parameters of decomposition processes of dehydrated complexes namely activation energy (E * ), frequency factor (A), entropy of activation (ΔS), enthalpy of activation (ΔH), and free energy change of the decomposition (ΔG * ) are estimated graphically from TGA data by employing the Coats–Redfern relation [32, 33] in the following form:\nRT\nE\nE\nRT\nE\nARwww T 303.2 2 1log )/(log( log\n*\n*2 * \n                   (1) (5)\n(3)\n(4)\nAC C\nEP TE\nD M\nAN U\nSC R\nIP T"
    }, {
      "heading" : "ACCEPTED MANUSCRIPT",
      "text" : "where W is the mass loss at the completion of the decomposition reaction. w is the\nmass loss up to temperature T, R is the universal gas constant and ϕ is the heating\nrate. Since 1-2RT/E * ≈1, the plot of the left-hand side of equation versus 1/T gives a\nstraight line whose slope (E * /R) and the pre-exponential factor (A) can be determined from the intercept. The other kinetic parameters; the entropy of activation (∆S * ), enthalpy of activation (∆H * ) and the free energy change of activation (∆G * ) were calculated using the following equations:\n∆S * = 2.303R log\nTK\nAh\nB\n∆H * = E * -RT (7) ∆G * = H * - T∆S * (8)\nWhere (KB) and (h) are Boltzmann’s and Plank's constants, respectively. The result of kinetic parameters for the prepared complexes is summarized in Table 5."
    }, {
      "heading" : "3. Pharmacology",
      "text" : ""
    }, {
      "heading" : "3. 1. DNA Binding and chemical nuclease activity studies",
      "text" : ""
    }, {
      "heading" : "3.1. 1Absorption spectroscopic studies",
      "text" : "The most commonly used method to study the interaction of DNA with metal\ncomplexes is the UV/Vis absorption spectroscopy. Binding experiments of the Schiff base metal complexes with CT-DNA in the buffer gave a ratio of UV absorbance at 260 and 280 nm of about 1.9 : 1, indicating that DNA was free sufficiently form protein [3, 4, 34]. The DNA concentration per nucleotide and polynucleotide concentrations were measured by absorption spectroscopy using at 260 nm the molar extinction coefficient (ε260 = 6600 M -1 cm -1 ) [35]. Absorption titration experiment was performed by maintaining the metal complex concentration constant (10 -3 M) and varying the concentration of DNA in interaction medium by adding 3–30 μM. While measuring the absorption spectra, an equimolar CT-DNA to pure buffer solution was added to complex solution and the reference solution to remove the absorbance of DNA itself. Based on the variation in absorption, the intrinsic binding constant (Kb) of the metal complex can be calculated according to the following equation:\n[DNA]/(εa–εf) = [DNA]/(εb–εf) + [Kb(εb–εf)] -1\nWhere the apparent absorption coefficient εa, εf and εb correspond to Aobs /[Mcomplex], the extinction coefficient of the free complex and the extinction coefficient of the compound when fully bound to DNA, respectively. Data were fitted to the above equation with an\n(5)\n(6)\n(9)\nAC C\nEP TE\nD M\nAN U\nSC R\nIP T"
    }, {
      "heading" : "ACCEPTED MANUSCRIPT",
      "text" : "intercept )(1 fb   and a slope )(1 fbbK   and Kb was determined from the ratio of\nthe slope to intercept [36]. The standard Gibb’s free energy for DNA binding was calculated from the following relation [37].\nb\no\nb KRTG ln"
    }, {
      "heading" : "3.1. 2. Viscosity experiments",
      "text" : "Viscosity experiments were carried on an Oswald micro-viscometer, immersed\nin a thermostated water-bath maintained at constant temperature at 25 ±1 o C. The flow times were recorded for different concentrations of the complex (10 - 250 µM), maintaining the concentration of DNA constant (250 µM). The solution was mixed by bubbling the nitrogen gas through the viscometer. The DNA s̀ concentration was maintained to be constant at 250 µM. The mixture was left for 10 min at 37 oC after addition of each aliquot of complex. The flow time was measured with digital stop watch. The experiment was repeated in triplicate to get the concurrent values. Data of measured viscosity was presented as (η/ ηo) 1/3 versus binding ratio R (R= [complex]/ [DNA] [2-5, 38], where η is the viscosity of DNA in the presence of complex and ηo that of DNA alone. The value of (η) and (ηo) were calculated by the following equation: η= (t- to)/to where, t is the flow time of buffer alone and to is the observed flow of DNA containing solution. Relative viscosities calculated from the relation (η/ ηo)."
    }, {
      "heading" : "3.1. 3. Agarose gel electrophoresis of DNA interaction with the investigated complexes",
      "text" : "The efficiency of synthesized Schiff base metal complexes with calf thymus\nDNA has been examined by the agarose gel electrophoresis method. Agarose was purchased from Fischer-Biotech (GC Health care). The samples were subjected to electrophoresis on prepared 1% agarose gel in TBE buffer (45 mM Tris, 45 Mm boric acid and 1Mm EDTA, pH 7.3). Then, 20 µl form each of the incubated complex and DNA . The mixture was incubated at room temperature for 30 min at 37 o C. After that, it was loaded with tracking dye (0.25 % bromophenol blue) on the gel. The electrophoresis was performed at constant voltage (100 V) for about 2 hr (until bromophenol blue had passed through 50 % of the gel) in TBE buffer. i.e. the end of DNA migration, the electric current was turned off at the end of electrophoresis. Then, the gel was stained by immersing it in water containing (0.5 µg/ml) ethidium bromide for 30 - 45 min at room temperature and later visualized under UV light using transilluminator and photographed with Panasonic DMC-LZ5 Lumix Digital camera [2-5, 39] and recorded in Fig .10.\n(6) (10)\nAC C\nEP TE\nD M\nAN U\nSC R\nIP T"
    }, {
      "heading" : "ACCEPTED MANUSCRIPT",
      "text" : ""
    }, {
      "heading" : "3.2 Antioxidant activity (AA) by ABTS method.",
      "text" : "The synthesized complexes were investigated by the ABTS assay (cf. Fig.11).\nThe ABTS assay is based on the scavenging ability of antioxidants to the long-life ABTS .+ radical cation [40]. A stock solution of the ABTS .+ radical cation was chemically created by mixing 0.2 ml (65 mmol dm 3 ) of ammonium peroxodisulfate solution with 50 ml of ABTS solution (1 mmol dm 3 , prepared in 0.1 mol dm 3 phosphate buffer pH 7.4). The mixture was left overnight and then 0.5 mL of ABTS .+ radical cation stock solution was mixed with 2 mL of phosphate buffer (pH 7.4) in a cuvette and the absorbance at 734 nm (AABTS) was measured. Subsequently, 0.5 ml of 0.5 mmol dm 3 of each metal complexes was added in the cuvette, the solution was quickly mixed, and after 60 s the absorbance (Acomplex) was measured at 734 nm. The decrease in absorbance (ΔA = AABTS - Acomplex) after 60 s was calculated. The decrease in absorbance caused by the addition of Trolox as the standard was measured by the same procedure for each concentration of Trolox (50–600 µmol/l) and the calibration curve for the decrease in absorbance (ΔA = AABTS - ATrolox) of Trolox vs. Trolox concentration was constructed by linear regression. AA of complexes were calculated on the basis of the curve of calibration of Trolox and expressed in µmol/L of Trolox equivalents (µmol TE/l)."
    }, {
      "heading" : "3.3 Cytotoxicity and antiviral activity",
      "text" : "Cytotoxicity and antiviral activity of all metal complexes were evaluated\nagainst herpes simplex virus-1 (KOS), herpes simplex virus-2 (G) and herpes simplex virus-1 TK-VMW1837 vero cell culture. The cytotoxic activities of all metal complexes were examined using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay as described previously [41, 42]. Cytotoxic concentration, required to cause a detectable microscopically alteration of normal cell morphology, was measured. Cytopathogenicity concentration required to decrease virus-induced cytopathogenicity by 50%, was determined."
    }, {
      "heading" : "3.3.1. Antiviral activity against Herps simplex Viruse (HSV)",
      "text" : "The antiviral activity of these compounds in cell culture was determined by\nusing calometric (MTT) dye assay with α herpes virus. The following viruses were investigated on human cells: herpes simplex virus type 1 (HSV-1) strain KOS; strain KOS; a thymidine kinase-deficient (TK−) HSV-1 KOS strain (resistant to acyclovir);\nAC C\nEP TE\nD M\nAN U\nSC R\nIP T"
    }, {
      "heading" : "ACCEPTED MANUSCRIPT",
      "text" : "herpes simplex virus type 2 (HSV-2) strain G and herpes simplex virus-1 TKVMW1837 (cf. Table 7).\nConfluent Vero cell cultures were treated with three non-cytotoxic\nconcentrations of the submitted sample during and after virus infection in two sets of experiments as follows:\n At 37 °C, 5 x 104 TCID50 of the virus was exposed to essential oil for one hr.\nThen 100 μl of the mixture were added to the cells cultured fluently in 96-well flat-bottom microtiter plate (100 μl).  Cells were treated with sample (100 μl) for one hr at 37°C. 5 x 104 TCID50 of\nthe virus (100 μl) were added, after one hr of incubation at 37°C.\n At CO2-incubator, all plates were incubated for 48 hrs.  The viability of cell (infected and non-infected) was evaluated according to the\nabsorbance values of formazan using the MTT inclusion assay, as described in cytotoxicity assay. The percentage of protection was calculated as follows:\nPercent protection = [(ODT) - (ODC) V]/[(ODC) M - (ODC) V] × 100\nWhere (ODT), (ODC) V and (ODC) M indicate absorbance of the test sample, the virusinfected control (no compound) and mock-infected control (no virus and no compound), respectively. The 50% inhibition concentration (IC50) is defined as the concentration of the essential oil that inhibits the viral infection by 50 %, which was calculated by regression curve analysis [43]."
    }, {
      "heading" : "3.3. 2.Antiviral activity against tobacco mosaic viruse (TMV)",
      "text" : "Tobacco mosaic virus (TMV) infects commercial plants including tobacco and\nrelated plants such as tomato and pepper. While not fatal, TMV affects the growth and productivity of these plants. Plants grown in Magenta® vessels were ready for mechanical inoculation with the virus within 2 weeks. Czech isolate of Turnip yellow mosaic virus (TYMV) [44] maintained in the virus collection at the Plant Molecular Biology Institute was used for this study. Singular virus infection was checked by gradient of sucrose density during the virus purification, electron microscopy, preparation of antiserum and serology. The inoculum was seated from infected B. pekinensis cv. Manoko plants with mosaic symptoms 3 weeks after inoculation. A leaf sample was homogenized in a mortar in a 1:10 (w/v) ratio with 0.1M phosphate buffer, pH 7.0, and filtered through 0.22μm sterile filters (Millipore). Mechanical inoculation of plants was conducted on the first 2 leaves in a\n(7)\nAC C\nEP TE\nD M\nAN U\nSC R\nIP T"
    }, {
      "heading" : "ACCEPTED MANUSCRIPT",
      "text" : "flowbox using a cotton pad soaked in inoculum mixed with carborundum powder. Control plants were inoculated only with buffer."
    }, {
      "heading" : "3.4. Antimicrobial activities",
      "text" : ""
    }, {
      "heading" : "3.4. 1. Organism culture and in vitro screening (Antibacterial activity)",
      "text" : "The antimicrobial activity was carried out at Mycological center, Assiut\nUniversity. The standard agar well diffusion method was followed to determine the activity of these compounds against the sensitive organisms one two Gram negative bacteria (pseudomonas aeruginosa and Escherichia coli); Gram-positive bacteria (Staphylococcus aureus). Each compound was dissolved in N, N -̀ dimethylsulfoxide at concentrations 10 and 25 mg/ml. DMSO was found to have no inhibition activity against any of the test organisms. So, it was used as solvent and also for control. 1 ml of a 24 h broth culture containing 106 CFU/cm 3 was placed in sterile Petri-dishes. At 45 o C, 15 ml of molten nutrient agar maintained, then poured into sterile petri-dishes and then allowed to solidify. Then holes of 6 mm diameter were formed in the a gar using a sterile cork borer and these holes were filled completely with the tested solutions. The plates were incubated at 37 o C for 24 h. The zones of inhibition were measured based upon zone size around the discs. Each inhibition zone was measured two times by caliper to get an average value. After incubation for 24 h at 37 o C, all plates were observed for zones of growth inhibition. Additionally, and for comparative purposes, standard Tetracycline (10, 25 mg/ml) was included in the test as a positive control. For data analysis, the clear zone of inhibition around each disk was measured (in mm) and compared to a known sensitivity drug in Fig. 12. 3.4. 2. Organism culture and in vitro screening (Antifungal activity)\nAntifungal activity of all complexes were studied against three fungal cultures\n(Aspergillus flavus, Candida albicans and Trichophyton rubrum) using disc diffusion method and shown in Fig. 13. The culture of fungi was purified by technique of single spore isolation. At 35 o C, the tested fungi were inoculated in Sabouraud dextrose broth medium (Hi-Media Mumbai) incubated for 48-72 h. Subsequently a suspension of about 1.6 × 10 4 – 6 × 10 4 c.f.u./ml was introduced on the sterile agar plates surface, and a sterile glass spreader was used for even distribution of the inoculums the discs measuring 6 mm in diameter were prepared from filter paper (Whatman No.1) and sterilized by dry heat for 1 h at 140 o C. Previously, the sterile discs soaked in known concentration of the test compounds were placed in Sabouraud dextrose agar SDA plates. For 7 days, the plates were inverted and incubated at 35 o C. The susceptibility (13)\nAC C\nEP TE\nD M\nAN U\nSC R\nIP T"
    }, {
      "heading" : "ACCEPTED MANUSCRIPT",
      "text" : "was assessed on the basis of diameter of inhibition against non-albicans and albicans strains of fungi. Moreover, the minimum inhibitory concentration (MIC) was determined by the technique of serial dilution and reported in Table 9. Furthermore, the activities of the prepared complexes were evidenced by calculating the activity index (cf. Table 10) according to the following relation [45]:"
    }, {
      "heading" : "4. Results and discussion",
      "text" : ""
    }, {
      "heading" : "4.1. Characterization of Schiff base ligand",
      "text" : "The npap ligand was synthesized by refluxing of 2-hydroxy-1-napthaldehyde\n(np) with 2-aminopyridine (ap) in 1: 1 molar ratio in absolute ethanol, Scheme 1. The compound was recrystallized from ethanol. It was characterized using single crystal Xray analysis, micro analytical, spectroscopic measurements."
    }, {
      "heading" : "4.1.1 Crystallography",
      "text" : "Single crystal X-ray analysis shows npap ligand belongs to monoclinic crystal\nsystem, space group P121/c1. Fig. 1(a, b) shows the ORTEP diagram with atomic numbering scheme and close packing structure for npap compound. Details of crystallographic parameters, data collection and refinements are listed in Table 1(a). Selected bond lengths (Å) and angles ( )o for npap ligand are listed in Table 1(b). The bond lengths of N(5)-C(4) and N(27)-C(28) are1.295(6) and 1.308(4) Å, respectively for npap compound which correspond to typical double bond characteristic. Bond angles C(26)-N(27)-C(28), 120.3(5) ;o C(6)-N(5)-C(4), 122.5(6)  o and O(20)-C(1)-C(29), 120.7(5)  ofor npap compound were also found. Form the hydrogen-bonding pattern (cf. Fig.1), there is also one intermolecular hydrogen bond of O—H …… O type in the structure that creates dimer.\n4.1.2. 1 H and 13 C NMR spectra\nThe synthesized ligands were characterized by the 1 H NMR (400 MHz and\nδ/ppm) in DMSO-d6. All the spectra are in good agreement with the proposed structure of the ligands. The 1 HNMR spectra of the synthesized Schiff base ligands showed the distinguished NMR signals. The 1 HNMR spectra of the prepared npap ligand show singlet due to hydrogen bond –OH proton at 15.19 ppm [46, 47]. The higher values of δ for the –OH group can be assigned to the presence of intramolecular hydrogen bonding\n(11)\nAC C\nEP TE\nD M\nAN U\nSC R\nIP T"
    }, {
      "heading" : "ACCEPTED MANUSCRIPT",
      "text" : "[48]. The characteristic proton of azomethine appeared at 9.82 ppm. The signals of CH pyridine are found at 8.26 and 7.90 ppm. Aromatic protons of napthyl ring found in the range of 7.74-6.86 ppm are assigned to aromatic protons. It was noticed that DMSO did not have any coordinating effect on the prepared ligand.\n13 C NMR spectral data were consistent with 1 H NMR spectral data. The\n13 CNMR spectra of the npap ligand have showed a peak at 176.9 ppm due to characteristic azomethine carbon. The ligand also exhibited signals at 108.6 (Cq, CCH=N), 115.8 (CH), 120.1 (CH), 122.0 (CH), 124.3 (CH), 124.4 (CH), 127.0 (Cq, naphthyl), 129.1 (CH), 129.6 (CH), 134.1 (Cq, -OH), 139.3 (CH m-py), 139.5 (CH mpy), 149.4 (CH p-py), 151.5 (CH, o-py), 153.6 (Cq-py)."
    }, {
      "heading" : "4.2. Characterization of metal complexes",
      "text" : ""
    }, {
      "heading" : "4.2.1. Elemental analysis and molar conductance measurements",
      "text" : "The metal complexes are solids, stable in air and partially soluble in ethanol but\nentirely soluble in DMF and DMSO. The structural characteristics of metal complexes were elucidated by employing elemental analysis, IR, UV–vis., TGA and cyclic voltammetry. The conductivity measurement has frequently been used in structure elucidation of metal chelate i.e. the possible mode of bonding within the limit of their solubility; they also provide a method of testing the degree of ionization of the complexes. All complexes have exhibited good solubility in DMF. The molar conductance values are found to be in the range 3.16 –7.42 Ω -1 mol −1 cm 2 , indicating the non-electrolytic nature of the complexes [49]. The non-electrolytic nature of the prepared complexes can be accounted by the deprotontation of the phenolic group of the ligand when it is coordinated to metals and presence of chloride or nitrate ions inside the coordination sphere. The suggested structure of Schiff base metal complexes are given in Scheme 2. 4.2.2 Magnetic moments measurements\nThe magnetic susceptibility measurements provide information regarding the\ngeometric structure of the complexes. The magnetic moment data of the solid-state complexes at room temperature are tabulated in Table 2. The magnetic moment value of Fe(II) complex was approximately 4.95 B.M. and referred as paramagnetic character and suggested high spin values for octahedral geometry of iron (II) metal center [3]. The magnetic susceptibility of Co(II) complex has a magnetic moment value of 4.46 B.M., which is in agreement with the reported value for tetrahedral geometry [50].The observed magnetic moment values of nickel (II) complexes were found to be in the\nAC C\nEP TE\nD M\nAN U\nSC R\nIP T"
    }, {
      "heading" : "ACCEPTED MANUSCRIPT",
      "text" : "range 2.50–2.74 B.M. These values indicate that presence of two unpaired electrons in the d-orbital, therefore, the Formed nickel complex has tetrahedral geometry [51]. The magnetic moment values [52] observed, for chromium (III) complexes is 3.80 B.M., and are close to theoretical spin only values for Cr 3+ (3d 3 system)."
    }, {
      "heading" : "4.2.3. Infrared spectra",
      "text" : "The formation of npap Schiff base ligand and its complexes and bonding modes\nwere inferred from characteristic band positions in FT-IR spectra. The IR spectra of complexes were compared with that of free ligand in order to mark the coordination sites. The IR spectrum of npap ligand shows a υ(C=N) peak at 1630 cm -1 and absence υ(C=O) of aldehyde, is indicative of Schiff` s base condensation. The IR of all Schiff base metal complexes exhibited υ(C=N) peak at 1603-1620 cm -1 and it is found that υ(C=N) are shifted by about 10 - 27 cm -1 to lower wavenumber compared to free ligand. This phenomenon shows to be due to the coordination of the azomethine nitrogen to the metal. Also, strong band in the free ligand appeared at 1586 cm -1 which are assigned to the ʋ (C=N) stretching vibration of pyridyl nitrogen [53].On complexation, this band is shifted to the lower frequency range of 1568- 1577 cm -1 indicating coordination through pyridine nitrogen [54]. Furthermore, from the spectroscopic behavior of simple metallic complexes of pyridine, it is known that after complexation the vibrations in the high frequency region are not appreciably shifted, whereas the ring deformation found at 604, 405 cm -1 in the free pyridine are shifted to higher frequencies [55]. In the present study, the in plane ring deformation bands are found at 654 cm -1 in the npap ligand. These bands are shifted to higher 25- 37 cm -1 wavenumber showing coordination via pyridine nitrogen [56]. The characteristic phenolic υ(OH) mode due to the hydroxyl group of 2- hydroxy-1-napthaldehyde moiety, present in the Schiff base ligand was observed at 3426 cm -1 [57]. The absence of this band in all the complexes explains the deprotontation of hydroxyl group. This facts further supported by decrease the in the absorption frequency of the phenolic υ(C-O) [58]. However, new bands in the region of 518-615 cm -1 and 453 - 482 cm -1 in the spectra of the metal complexes appeared and can be assigned to stretching frequencies of (M-O) and (M-N) bonds, respectively [59]. Also, a weak broad band in the range 3434 - 3476 cm -1 was observed and it indicates to the presence of lattice water in the metal complexes [60]. The other series of weak bands between 3000 -3064 cm -1 and can be attributed to ʋ (CH) aromatic stretching vibration [61]. Noteworthy, the existence of coordinated water is further confirmed by the appearance of non-ligand band in 820-835 cm -1 region, which is assignable to the\nAC C\nEP TE\nD M\nAN U\nSC R\nIP T"
    }, {
      "heading" : "ACCEPTED MANUSCRIPT",
      "text" : "rocking mode of water [62]. In Co(II) and Ni(II) complexes, new bands appeared due to coordination of nitrate group inside the coordination sphere. The characteristic frequencies of the coordinating nitrate group in nickel and cobalt complexes possess three non-degenerated modes at 1423 cm -1 ʋ (NO2)asy, 1365- 1367 cm -1 ʋ (NO2)sy and 810 cm -1 ʋ (NO) [63]. Schiff base ligand (npap) behaves as monobasic tridentate ligand and binds to the metal ions via the azomethine nitrogen, phenolic oxygen and pyridine nitrogen [64-67].\n4.2.4. Electronic spectra\nUV-Vis spectra are important item for most chemical characterization to get\nimportant information about the structural aspects of complexes. The UV-Vis absorption of investigated ligand and its complexes were carried in DMF solvent at the wavelength range 200– 800 nm and at 298 K. The numerical values of the maximum absorption wavelength (εmax) and the molar absorptivity (λmax) were listed in Table 3 and the spectra were presented in Fig. 2. The Schiff base ligand exhibits absorption bands in ultraviolet region at 391 and 427 nm. The band around 391 nm is due to the n π *\ntransitions of the non-bonding electrons present on the nitrogen of the azomethine group in the Schiff base. The second band at λmax > 400 nm involves *n transitions of the donating groups [68]. On complexation this band disappeared suggesting the coordination of azomethine nitrogen to the metal ion, as the formation of the metal– nitrogen bond stabilizes the electron pair on the nitrogen atom [69]. Thus addition of metal ion to the ligand solution causes distinguishable changes in the visible absorption spectra of the ligand, suggesting an instantaneous complex formation in solution [70, 71]. The designed complexes display a characteristic band centered at λmax = 322– 390 nm, due to an intramolecular charge transfer transition taking place in the complexed ligand. Moreover, there is a band shown in the region 403 - 464 nm, which can be attributed to charge transfer from ligand to metal. Furthermore, the MCTL band is followed by a broad band from 567 to 678 nm assigned as d–d transitions. The former band is probably due to )()( 1 3 1 3 PTFT  for npapNi, (P)TA 1 4 2 4  for npapCo respectively. This indicates tetrahedral geometry for the complex [72]. Electronic spectra of iron and copper complexes exhibited bands at 586, 644 nm, assignable to gg ET 55  , gg TE 22  transitions characteristic of octahedral geometry [73, 74]. On other hand, Cr(III) complex exhibited band at 576 nm, is assigned to )(2 4 2 4 FgTgA  transition.\nAC C\nEP TE\nD M\nAN U\nSC R\nIP T"
    }, {
      "heading" : "ACCEPTED MANUSCRIPT",
      "text" : ""
    }, {
      "heading" : "4.2.5. Evaluation of the stiochmetry of the prepared Schiff base ligands complexes:",
      "text" : "The stoichiometry of the tested complexes was determined by applying the\nspectrophotometric continuous variation [4] and molar ratio methods [2]. The curves of continuous variation and molar ratio methods were used for the determination of chelation stoichiometry. The curves of continuous variation methods displayed maximum absorbance at mole fraction Xligand = 0.56 in Co(II), Ni(II) and Cr(III) complexes, which indicates the formation of complex with metal ion to ligand ratio 1: 1 as presented in Scheme 2. The maximum change will occur when the mole ratio of the reactants is close to the optimum ratio which is the stoichiometric ratio in the chemical equation. In the case of iron complex, maximum of absorbance at mole fraction at Xligand = 0.65 - 0.70 implicates a 1: 2 (metal ion to ligand) molecular association. Moreover, the data resulted from applying the molar ratio method assist the same metal ion to ligand ratio of the prepared complexes cf. Figs 3, 4."
    }, {
      "heading" : "4. 2.6. Evaluation of the apparent formation constants of the synthesized complexes",
      "text" : "The obtained the apparent formation constants values indicate the high stability\nof the prepared complexes. The values of (Kf) for the prepared complexes increase in the following sequence: npapFe > npapCr > npapNi > npapCo. Moreover, the values of log Kf (stability constant) and Gibbs free energy (ΔG * ) of investigated complexes are cited in this Table 4. The negivate values of Gibbs free energy indicate that the reaction is spontaneous and favorable.\nThe stability range of the studied complexes was found to be in the pH range =\n6 – 10 for npapFe, pH = 5 - 10 for npapCr, pH = 4 – 11 for npapCo and pH = 4 – 10 npapNi, according to the obtained pH - absorbance curves (Fig. 5).This means that M(II) ion greatly stabilizes the tested Schiff base in this range. Accordingly, these ligands can be used as masking reagents of M(II) ions in that pH range."
    }, {
      "heading" : "4.2.7. Thermogravimetric analysis and Kinetic studies",
      "text" : "One of the features in TGA data concerning the associated water and/or ethanol\nmolecules within the complexes supports the elemental analyses [75]. The complexes were succumb to a TGA analysis ambient temperature up to 750 o C under nitrogen atmosphere with heating rate 10 o C /min. The experimental results revealed that the degradation occurred in multiple stages. The assignment of different decomposition\nAC C\nEP TE\nD M\nAN U\nSC R\nIP T"
    }, {
      "heading" : "ACCEPTED MANUSCRIPT",
      "text" : "steps are given in Table 5. The mass losses obtained from TGA curves are in a good agreement with the theoretical values. All complexes undergo decomposition in five stages expect Cr(III) and Fe(II) complexes. Cr(III) complex decompose in six stages. On other hand, Fe(II) complex decompose in five stages. The first stage of decomposition for Cr(III), Fe(II), Co(II) and Ni(II) complexes occurs in the temperature ranges 27- 110 o C, 15-135 o C, 15- 110 o C and 16- 110 o C, which could be referred to the release of loosely bound lattice water molecules with mass losses of 2.25 %, 6.17 %, 2.31 % and 8.89 % respectively. All complexes exhibited no mass loss at temperature range 110- 210 o C expect Cr(III) complex which has mass loss of 4.48 % due to the removal of one coordinated water molecule. By increasing the temperature over 210 o C, gradual weight loss of the different complexes takes place, which can be explicated to complete decomposition of the ligand moiety around the different metal ions. In the final stage all the studied metal complexes are converted into their corresponding metal ions as a residue.\nIn recent years, there has been growing interest in determining the rate\ndependent parameters of solid-state decomposition reactions by analysis of TGA curves. Several equations have been proposed as means of analyzing a TGA curve and obtaining values for kinetic parameters. One of the major different methods were used to evaluate the kinetic thermodynamic parameters is the Coats–Redfern method [32].\nThe thermo kinetic parameters of the decomposition steps for metal complexes\nare listed in Table 5. Form the obtained data, the following remarks can be pointed out:"
    }, {
      "heading" : "Thermodynamic parameters",
      "text" : "The entropy (∆S * ), enthalpy (∆H * ) and free energy (∆G * ) of activation were calculated for the metal complexes using standard equation [32].\n The entropy (∆S*) values for the prepared complexes were found to be negative.\nThis denotes that the activated complex is more ordered than the reactants and the thermal decomposition reaction is slower than normal. The negative values of ∆H * means that the decomposition processes are exothermic.  The high positive values of the free energy of activation (∆G*) for most of the\nsteps in the decomposition reactions of the synthesized complexes means that the decomposition reactions are slower than normal ones and reveals that the free energy of the final residue is higher than that of the initial compound; hence all decomposition steps are non- spontaneous processes [76]. Moreover, the values of the activation, ΔG * increases significantly for the subsequent decomposition stages of a given complex. This is due to increasing the values of\nAC C\nEP TE\nD M\nAN U\nSC R\nIP T"
    }, {
      "heading" : "ACCEPTED MANUSCRIPT",
      "text" : "TΔS * significantly from one step to another which overrides the values of ΔH * [77]."
    }, {
      "heading" : "Kinetic parameters",
      "text" : "The thermal decomposition of the complexes is not simple and the processes generally involve overlapping steps which gather with the great diversity of possible intermediate products precludes exhaustive interpretation the thermal decomposition patterns for many complexes.\n In all complexes dehydration is being first step, whenever they containing water\nmolecules, loss of the side chain of the ligands is being the second step and loss of the ligand fragments are considered the third or later with the formation of the ultimate products.\n Generally, for the synthesized complexes there are varieties in the strength of the\ncoordination bond formed and the thermal stability depends mainly on the type of the metal ion and ligands used.  There is a direct relation between (E*) and (A) for the obtained complexes. The\nrelatively low values of (A) indicate the slow nature of the pyrolysis reaction."
    }, {
      "heading" : "4.2.8 Cyclic voltammetry",
      "text" : "Figs. 6a and 6b illustrate the cyclic voltammograms of npapCo and npapCr\ncomplexes in 0.2 M phosphate buffer solution (pbs, pH 7.01) at scan rate of 50 mV s -1 . The complexes demonstrate no oxidative or reductive waves in the potential range 0.0 to 1.6 V. This indicates that the complexes of Co and Cr are electro-inactive.\nWhile Fig. 6c illustrates the cyclic voltammograms of npapFe complex in 0.2\nM PBS (pH 7.01) at different scan rates (10, 20 30 mV s -1 ) . The complex demonstrates an oxidative wave positive to reference electrode (Ag/ AgCl) in the potential range 0.35 to 0.85 V. The oxidation wave is assigned to the process of Fe(II) to Fe(III) i.e., the oxidation is primarily metal-centered electron extraction. It is obvious that the oxidation process of the complex is irreversible in nature. A linear log–log variation, log peak current, log ip, versus log scan rate, log ʋ , for the oxidation wave is obtained with slope of 0.879. These results indicate that the oxidation wave of the complex is adsorptioncontrolled in nature."
    }, {
      "heading" : "4.2. 8. Particle size measurements",
      "text" : "TEM is one of the most powerful analytical tools available which can give\ndirect structural and size information of the nanoparticles. TEM images and the calculated histogram for nickel and copper complexes are screened in (cf. Fig. 7 (a- d)).\nAC C\nEP TE\nD M\nAN U\nSC R\nIP T"
    }, {
      "heading" : "ACCEPTED MANUSCRIPT",
      "text" : "In Fig. 7(a, b), the TEM image indicates that a sphere-like structure for Cr(III) and Fe(II) complex which is considered as a self- assembled or agglomerated from nano particles structure as observed. The calculated histogram shows that particle size between 25- 80 nm. Unlike, Co(II) complex has fiber structure with particle size 35 nm ( cf. Fig 7(c)). On other hand, Ni(II) complex has rod shape (as shown in Fig. 7(d)) with average diameter 250 nm."
    }, {
      "heading" : "5. Biological evaluation of synthesized complexes",
      "text" : ""
    }, {
      "heading" : "5.1 DNA binding studies",
      "text" : ""
    }, {
      "heading" : "5.1.1 Electronic spectral studies",
      "text" : "Electronic absorption spectroscopy has been widely utilized to determine the\nbinding ability of metal complexes with DNA. The binding ability of the studied metal complexes with CT-DNA was investigated by measuring the spectral changes of their electronic spectra during the interaction with DNA. Complex binding with DNA through intercalation usually inferred from hypochromism and bathochromism, because intercalation involves a strong stacking interaction between base pairs of DNA and aromatic chromophore bound ligand. This strong stacking interaction is owing to the contraction of CT-DNA in the helix axis and its conformational changes. On the other hand, hyperchromism results from the secondary damage of DNA double helix structure, in which the amplitude of hyperchromism is indicative of partial or nonintercalative binding modes [78]. The absorption spectrum of npapFe in the absence and presence of CT DNA is presented in Fig. 8. As the DNA concentration is grown, the MLCT transition band of npapFe complex at 414 nm exhibits hypochromism of about 55.44 % and bathochromism of 29 nm respectively. Furthermore, the intense absorption bands with maxima of 314, 363 and 402 nm for npapCr, npapCo, npapNi exhibit hypochromism of about 37.72 %, 41.10 %, 35.11 % and bathochromism of 33, 1 and 44 nm, respectively. These spectral characteristics may suggest a mode of binding that involves a stacking interaction between the aromatic chromophore and the DNA base pairs. The hypochromism spotted for the bands of these four compounds are escorted by a small red shift which is less than 33 nm. The above phenomenon implies that these compounds interact with CT DNA by intercalative binding mode. To compare quantitatively, the affinity of these studied compounds binding to DNA, the intrinsic binding constant (Kb) has been evaluated from previous equation no 9.The extent of binding strength of complexes is quantitatively determined by measuring intrinsic binding constants Kb (Table 6). The intrinsic binding constants for Cr(III), Fe(II), Co(II), Ni(II) and complexes are to be found 8.56×10 4 , 1.74×10 6 , 2.36×10 4 and 2.25 × 10 5 M -1 respectively. The investigated complexes could bind to\nAC C\nEP TE\nD M\nAN U\nSC R\nIP T"
    }, {
      "heading" : "ACCEPTED MANUSCRIPT",
      "text" : "DNA via an intercalative mode with the sequence: npapFe > npapNi > npapCr > npapCo. The value of binding constant of Fe(II) complex with DNA is higher than that of cisplatin (5.73 ± 0.45 x 10 4 M -1 , ethidium bromide (1.4 x 10 6 M -1 ) and our previously reported complexes 0.71-1.47 x 10 5 M -1 [79], and relatively lower than the metallointercalators [Ru(bpy) 2 (HBT)] 2+ (5.71 x 10 7 M -1 ) [80]. The higher value of intrinsic binding constant for Fe(II) complex, because particle size reach to nanometer scale. Aslo particle size, shape and surface area play leading role in interaction of materials with biological system. The reduction in particle size to nanometer scale improves their properties compared to its bulk properties such as physical, electronic, and magnetic properties. In this context, nanoparticles can be considered as beneficial platforms as they have unique advantages such as high surface area to volume ratio and allow many functional groups to be attached to a nanoparticle, which can seek out and bind to selected tumor cells. Additionally, the small size of nanoparticles allows them to preferentially accumulate at tumor sites. Basically, shape dependent nanotoxicity affects the membrane wrapping processes in vivo during endocytosis or phagocytosis [80]. It has been observed that endocytosis of spherical nanoparticles is easier and faster as compared to rod shaped or fibre like nanoparticles [81]."
    }, {
      "heading" : "5.1.2 Viscosity studies",
      "text" : "Viscosity measurements are regarded as the least controversial and the most\nrigorous means of testing the binding mode of DNA in solution [2-5]. To further clarify the DNA-binding mode of complexes, viscosity measurements on solutions of CT-DNA incubated with the metal complexes were carried out. It is well-known that a classical intercalation model leads to an apparent increase in the viscosity of DNA solution due to base-pairs are pushed apart and hence an increase in overall of DNA length. In contrast, a partial, non-classical intercalation of compounds could bend (or kink) the DNA helix and decrease its effective length and, concomitantly, its viscosity [83]. The effects of all compounds on the viscosity of CT-DNA are shown in Fig. 9. As can be seen in Fig. 8 with increasing amounts of the complexes, the relative viscosity of DNA increases continuously to some extent. The results thus provide strong evidence for the interaction of complexes with CT-DNA by intercalation modes. Moreover, the large increase in the relative viscosity revealed that npapFe and npapCr is better intercalator than npapCo and npapNi, which are consistent with our foregoing hypothesis that electronic effects of introduction of larger planar aromatic rings on 2-hydroxy-1-napthaldehyde based ligands play a key role in DNA-binding affinities.\nAC C\nEP TE\nD M\nAN U\nSC R\nIP T"
    }, {
      "heading" : "ACCEPTED MANUSCRIPT",
      "text" : "5.1.3 Gel electrophoresis\nThe interaction of the investigated complexes with DNA was studied by\nagarose gel electrophoresis and the results were represented in Fig. 10. (Lane 1- 4, are CT-DNA + metal complex; while Lane 5, 6 are blank and CT-DNA). The variation in DNA–cleavage efficiency of the investigated complexes was attributed to their difference in binding ability to DNA. The intensity of lanes were increased in the sequence npapFe > npapCr > npapNi > npapCo and these are in a good agreement with binding constant values of the investigated complexes with CT-DNA (cf. Table 6)."
    }, {
      "heading" : "5.2 Antioxidant activity",
      "text" : "It is well known that reactive oxygen species (ROS) created during biochemical\nprocesses in body system, such as superoxide anion, hydroxyl radical, and hydrogen peroxide, are widely reactive and potentially damaging transient chemical species. The oxidative casualties caused by ROS on lipids, proteins, and nucleic acids may generate various chronic diseases, such as coronary heart disease, atherosclerosis, cancer, and aging. Hence, to prevent the free radical damage in the body, it is important to manage drugs that may be rich in antioxidants. The antioxidant assay study was carried out using Fe(II), Co(II) and Cr(III) complexes with ABTS radicals, while Trolox was used as a standard."
    }, {
      "heading" : "5.2.1. ABTS Radical scavenging activity",
      "text" : "An important feature of antioxidants is the proton radical scavenging. A well-\nknown protonated radical like 2,2 -̀azinobis-3-ethylbenzothiazoline-6-sulfonic acid (ABTS) possess characteristic absorbance maxima at 734 nm which decreases with the scavenging of the proton radicals. Fe(II), Co(II) and Cr(III) complexes exhibited\nThe radical activity was found 184.0, 62.0 and 46.0 µmol TE/L for complexes\nof npapFe, npapCo and npapCr respectively. Fig. 11 illustrates the percent inhibition % of radical for the three investigated complexes. It is obvious that npapFe shows the strongest potent radical scavenging activity with percent of 58.60 %. These results also confirm that npapFe has strong electro-activity towards free radicals."
    }, {
      "heading" : "5.3. Cytotoxicity and antiviral activity against Herpes Simplex and Tobacco Mosaic",
      "text" : ""
    }, {
      "heading" : "Viruses.",
      "text" : "5.3.1. Cytotoxicity\nAC C\nEP TE\nD M\nAN U\nSC R\nIP T"
    }, {
      "heading" : "ACCEPTED MANUSCRIPT",
      "text" : "Cytotoxicity assays are fundamental for the initial phases of antiviral drug\ndevelopment because they define the concentrations to be used, eschewing cell damage and assuring selectivity for the virus in vitro. The assessment of the cytotoxicity is usually performed by cell viability assays, such as the dye up take by non- viable cells or by alteration in cell functions [84]. MTT assay is probably one of the most widely used calometric indicators of cell viability, and it estimates mitochondrial cellular function based on the enzymatic reduction of the tetarzolium salt by the mitochondrial dehydrogenase in the viable cells [85]. MTT assay is used to determine the cytotoxicity of the potential drugs and other toxic compounds [86].In this study, the cytotoxicity of the tested complexes was evaluated by this assay and the CC50 values are expressed in μg/ml. The higher CC50 value was observed for npapNi complex, indicating low side effects."
    }, {
      "heading" : "5.3.2. Antiviral activity",
      "text" : "The antiviral activity of tested complexes against Herpes simplex virus-\n1(KOS), Herpes simplex virus-2 (G) and Herpes simplex virus-1TK-VMW1837 is listed in Table 7. IC50 is employed to stand for antiviral activity of the tested complexes. The smaller IC50 values in the same conditions are the higher the cell growth inhibitory potency. The lowest IC50 values are observed for npapFe and npapCr complexes. Their activity of tested complexes may be refer to many factors:\n Structure of starting materials: 2-aminopyridine is well known example of\nheteroaromatic organic compounds associated with diverse biological properties.\n Effect of chelation: the significant activity of metal complexes in inhibiting\nability, due to incorporation of metal ions increases the inhibition of cell growth [87].\n Effect of particle size: Particle size and surface area play a major role in\ninteraction of materials with biological system. Seemingly, reducing the size of the materials leads to an exponential increase in surface area relative to volume, thereby making the nanomaterial surface more reactive on itself and to its contiguous milieu [88].\n5.4. Antimicrobial activity"
    }, {
      "heading" : "5.4.1. Antibacterial activity",
      "text" : "In vitro antibacterial testing of the investigated compounds was tested against\none Gram-negative bacteria, namely, Staphylococcus aureus (ATCC 25923) and two Gram-negative bacteria, namely, Pseudomonas aeruginosa (ATCC 19582) and\nAC C\nEP TE\nD M\nAN U\nSC R\nIP T"
    }, {
      "heading" : "ACCEPTED MANUSCRIPT",
      "text" : "Escherichia coli(ATCC 25922) using well diffusion method. From the results in Fig. 12 it was observed that all investigated metal complexes are more efficient than the free ligand and such enhanced activity of metal chelates is due to the lipophilic nature of the metal ions in complexes [89]. It also suggests that the complexes possess antibacterial activity inhibiting multiplication process of the microbes by blocking their active sites. The Cr(III) complex exhibited higher bactericidal activities than other complexes against all S. aureus, P. aeruginosa, and E. coli. The variation in the activity of different complexes against tested organisms depends on either the impermeability of cells of the microbes or difference in ribosomes of microbial cells. The higher biological activity of metal complexes than that of npap ligand can be explained on the basis of Overtone’s concept and Tweedy’s chelation theory [90]. On chelation, metal ion polarity is reduced to a greater extent due to the overlapping of the ligand orbital and partial sharing of positive charge of metal ion with donor groups [91]. Further, the delocalization of the - electrons is increased over the whole chelate sphere and enhances the lipophilicity of the complex. The lipophilic nature of the central metal atom is also increased upon chelation, which subsequently favors the permeation through the lipid layer of cell membrane. Notably, the normal cell process may be affected by the formation of hydrogen bond through the azomethine nitrogen atom with the active centers of cell constituents leading to interference with the cell wall synthesis. The bioactivity of the ligand and its complexes is found to be in the following order: Cr(III) > Ni(II)> Fe(II) > Co(II) > npap. The difference in antimicrobial activity is due to the nature of metal ions and also the cell membrane of the microorganisms."
    }, {
      "heading" : "5.4.2. Antifungal activity",
      "text" : "To provide a medicinal scope in the field of bioinorganic chemistry,\nconsequently, the metal complexes synthesized have been evaluated for their antifungal activity. The antifungal tests were carried out using the disc diffusion method. The prepared compounds were screened in vitro in order to find out the antifungal activity against Aspergilus flavus, Candida albicans and Trichophyton rubrum. The results of the antifungal studies are presented in Fig. 13. All the metal complexes exhibited higher toxicity than the free ligand under identical experimental conditions against the same organisms. Moreover, all metal complexes are having higher antifungal activities than Schiff base ligand. The increase in the antifungal activity of the metal complexes inhibits multiplication process of the microbes by blocking their active sites. Such increased in activity upon metal chelation can be explained on the basis of Tweedy’s\nAC C\nEP TE\nD M\nAN U\nSC R\nIP T"
    }, {
      "heading" : "ACCEPTED MANUSCRIPT",
      "text" : "chelation theory [90]. The chelation also increases the lipophilic nature and the interaction between the metal ion and the lipid is favored. This may lead to the breakdown of the permeability barrier of the cell resulting in interference with the normal cell processes. The chelation is not the only factor for antimicrobial activity; it is complicate blend of several aspects such as nature of the metal ion and the ligand, the geometry of the metal complexes, the lipophilicity, the presence of co-ligands, the steric and pharmacokinetic factors."
    }, {
      "heading" : "Conclusion",
      "text" : "In this paper, the coordination behavior of N2O imine ligand obtained from the\nreaction of 2-hydroxy-1-napthaldehyde and 2-aminopyridine is described. The resulted Schiff base ligand was characterized by single crystal X-ray analysis, IR, 1 H and 13 C"
    }, {
      "heading" : "NMR",
      "text" : "spectra. It crystallizes in monoclinic space group P121/C1. Four novel Cr(III), Fe(II), Co(II) and Ni(II) complexes have been elucidated by spectral, thermal, cyclic voltammetry and analytical studies. Based on IR, electronic spectra and magnetic susceptibility results suggest tetrahedral geometry for Co(II) and Ni (II) complexes and octahedral geometry for Fe(II) and Cr(II) complex. In all complexes, the Schiff base ligand acted as tridentate and coordinated to metal ion through the azomethine, pyridine nitrogen base and phenolic-oxygen. Initially, the binding behaviors of the metal complexes with DNA were investigated using absorption spectroscopy, viscosity and gel electrophoresis. The results assured the fact that the complexes could bind to CT-DNA via intercalation. In addition, the Fe(II) complex also showed excellent radicalscavenging activities than other metal complexes. Morover, iron (II) complex exhibited better toxicity against herpes simplex and tobacco mosaic viruses. The antimicrobial screening results of all the newly synthesized metal complexes showed remarkable activity than the free ligand. Furthermore, the antibacterial activity has been explained on the basis of chelation theory. Hence, from all these extensive observations, it was concluded that the cytotoxic activity of the Fe(II) complex could be exploited for the design of novel antiviral drug employing reported ligand metal combination.\nAC C\nEP TE\nD M\nAN U\nSC R\nIP T"
    }, {
      "heading" : "ACCEPTED MANUSCRIPT",
      "text" : ""
    }, {
      "heading" : "985, 2-3, (2011) 330–338.",
      "text" : "[9] F. Arjmand, F. Sayeed, and M. Muddassir, J. Photochem. Photobiol. B Biol., 103, 2 (2011) 166–179. [10] C. N. Sudhamani, H.S. B. Naik, T.R. R. Naik, and M.C. Prabhakara, Spectrochim. Acta A72, 3 (2009) 643–647. [11] H.F. Ji, H.Y. Zhang, Chem. Res. Toxicol. 17 (2004) 471–475. [12] S. Adsule, V. Barve, Di Chen, F. Ahmed, Q.P. Dou, S. Padhye, F.H. Sarkar, J. Med. Chem. 49 (2006) 7242–7246. [13] D.R. Alvira, L.G. Navarro, M.A. Gotor Lazaro, and E. R. Collado, Ann. Med. Int.,"
    }, {
      "heading" : "12 (1995) 139–149.",
      "text" : "[14] K. Olson, P. Macias, S. Hutton, W.A. Ernst, G. Fujii, J.P. Adler-Moore, Vaccine"
    }, {
      "heading" : "28 (2009) 548–560.",
      "text" : "[15] M.P. Nicoll, J.T. Proenca, S. Efstathiou, FEMS Microbiol Rev., 36: (2012) 684– 705. [16] B.S. Holla, B. Veerendra, M.K. Shivananda, B. Poojary, Eur. J. Med. Chem., 38 (2003) 759. [17] H.F. Abd El-Halim, F.A. Nour El-Dien, G.G. Mohamed, N.A. Mohamed, J. Therm. Anal. Calorim., 109 (2012) 883–892.\nAC C\nEP TE\nD M\nAN U\nSC R\nIP T"
    }, {
      "heading" : "ACCEPTED MANUSCRIPT",
      "text" : "[18] A. Jarrahpour, D. Khalili, E. De Clercq, C. Salmi, J.M. Brunel, Molecules, 12 (2007) 1720–1730. [19] G.H. Clever, M. Shionoya, Coord. Chem. Rev., 254 (2010) 2391–2402. [20] A.M. Shaker, A.M. Awad, L.A.E. Nassr, Synth. React. Inorg. Metal – Org. Chem."
    }, {
      "heading" : "33 (1) (2003) 103–107.",
      "text" : "[21] E.V. Sekhar; K. N. Jayaveera and S. Srihari, J. Chem. Pharm. Res., 4(12) (2012) 5121-5125. [22] H.T. S. Britton, Hydrogen Ions, fourth ed., Chapman and Hall, London, UK, 1952. [23] Sheldrick, G.M. (1986). SHELXS86. Program for the solution of crystal structures. Univ. of Gottingen, Federal Republic of Germany. [24] Paul W. Betteridge, J. Robert Carruthers, Richard I. Cooper, Keith Prout and David J. Watkin, J. App. Cryst., 36, (2003)1487. [25] Watkin, D.J., Prout, C.K. & Pearce, L.J. CAMERON, Chemical Crystallography Laboratory, OXFORD, UK (1996). [26] Canpolat and kaya, 2002; El-Tabl et al; 2008; Abdel-Rahman et al, (2013). [27] E. Canpolat, M. Kaya, J. Coord. Chem., 55 (2002) 961–968. [28] A.S. El-Tabl, F.A. EL-Saied, A.N. Al-Hakimi, J. Coord. Chem., 61 (15) (2008) 2380–2401. [29] K. Mohammadi, M. Rastegari, Spectrochim Acta A 97 (2012) 711–716. [30] P. Job, Ann. Chim. 9 (1928) 113–134 [31] A.M. Shaker, A.M. Awad, L.A.E. Nassr, Synth. React. Inorg. Metal – Org. Chem.,"
    }, {
      "heading" : "33 (1) (2003)103–107.",
      "text" : "[32] A. W. Coats, I. P. Redfern, Nature 20 (1964) 68. [33] R.M. Issa, A.A. Hassanein, I.M. El-Mehasse, R.I. Abed, El-Wadoud, Spectrochim Acta A 65 (2006) 206–214. [34] J. Marmur. J. Mol. Biol, 3(1961) 208-218. [35] M.E. Reichmann, S.A. Rice, C.A, Thomas, P. Doty, J. Am. Chem. Commun., 6 (2003)193- 196. [36] A. Wolf, G.H. Shimer, T. Meehan, Biochem., 26 (1987) 6392–6396. [37] D. Sabolová, M. Kozurková, T. Plichta, Z. Ondrušová, D. Hudecová, M. Simkovic, H. Paulíková, A. Valent, Inter. J. Bio. Macromol., 48 (2011) 319–325. [38] S. Satyanarayana, J.C. Dabroniak, J.B. Chaires, Biochem., 31(1992) 9319– 9324. [39] M. Vujcic, S. Tufegdzic, Z. Vujcic, M.J. Gašic, D. Sladic, J. Serb. Chem. Soc., 72 (2007) 1265–1269.\nAC C\nEP TE\nD M\nAN U\nSC R\nIP T"
    }, {
      "heading" : "ACCEPTED MANUSCRIPT",
      "text" : "[40] D. Villano, M. S. Fernandez-Pachon, A. M.Troncoso & M. C. Garcia-Parrilla, Talanta 64 (2004) 501–509. [41] H. Mueller, M. U. Kassack, and M. Wiese, J. Biomol. Screen, 9(6) (2004) 506– 515. [42] V. Kumar Chityala, K. Sathish Kumar, R. Macha, P. Tigulla, and Shivaraj, J. Bioinorg.Chem. Appl., 2014, (2014) 11. [43] GraphPad Prism version 5.04 for Windows, GraphPad Software, La Jolla California USA, 2010.www.graphpad.com. [44] J.ˇSpak, A.Holy, D. Pavingerová, I. Votruba, V. Spaková, K. Petrzik, Antiviral Research 88 (2010) 296–303. [45] S. Gopalakrishnan, R. Rajameena, E. Vadivel, Int. J. Pharmaceut. Sci. Drug Res. 4 (1) (2012) 31–34. [46] H. Ranganathan, D. Ramaswamy, T. Ramasami, M. Santappa, Chem. Lett., (1979) 1201. [47] A.A.M. Belal, I.M. El-Deen, N.Y. Farid, Rosan Zakaria, Moamen S. Refat, Spectrochim Acta A 149 (2015) 771–787. [48] S.K. Gupta, C. Anjana, N. Sen, R.J. Butcher, , J. P. Jasinski, J. A. Golen, Polyhedron 89, (2015) 219-231. [49] (a) W.J. Geary, J. Coord. Chem. Rev. 7 (1971) 81–120.; (b) S. Chandra, S. Raizada, M. Tyagi, P. Sharma, Spectrochim. Acta A 69 (2008) 816. [50] (a) S.F.A Kettle,T.Nelson, Sons Ltd Coordination Compounds, London (1969). 1. Aufl., VII, 220 S., geb. s 35.; (b) F.A. Cotton, G. Wilkinson, C.A. Murillo, M. Bochmann, Sixth ed., Advanced Inorganic Chemistry, Wiley–Interscience, New York, (1999) p. 1376. [51] T. M. A. Ismail, A.A. Saleh, M. A. El Ghamry, Spectrochim Acta A 86 (2012) 276- 288. [52] R.C. Mehrotra & J.V. Singh, J. Inorg. Chem., 23 (1984) 1046. [53] G.G. Mohamed, Spectrochim Acta A 64 (2006) 188- 195. [54] E.Q. Castro, B. Bernes, A.T. Benavides, R. Contreras, H. Noth, Polyhedron 19 (2000) 1479. [55] K. Nakamoto, Infrared and Raman spectra of Inorganic and coordination compounds, Fourth ed., Wiley, New York (1980). [56] (a) D.X. West, J.K. Swearingen, J.V. Martinez, S.H. Ortega, A.K. El-Sawaf, F.V. Meurs, A. Castineiras, I. Garcia, E. Bermejo, Polyhedron 18 (1999) 2919.; (b) M.A.\nAC C\nEP TE\nD M\nAN U\nSC R\nIP T"
    }, {
      "heading" : "ACCEPTED MANUSCRIPT",
      "text" : "Zayed, F.A. Nour, El Dien, G.G. Mohamed, N.E.A. El- Gamel, Spectrochim Acta A 60 (2004) 2843-2852. [57] J.E. Kovacic, Spectrochimi. Acta Part A 23(1967) 183-187. [58] (a) K. Naresh Kumar, R. Ramesh, Spectrochim. Acta A 60 (2004) 2913.; (b) G.G. Mohamed, C.M. Sharaby, Spectrochim. Acta A 66 (2007) 949. [59] K. Nakamoto, Infrared spectra of Inorganic and coordination compounds, Wiley, New York, (1970). [60] M.E. Hossain, M.N. Alam, J. Begum, M.A. Akbar, M. Nagimuddin, F.E. Smith, R.C. Hynes, Inorg. Chim. Acta, 249 (1996) 207-213. [61] A.M. Abdel-Mawgoud, Synth. Inorg. Met. Org. Chem., 28 (4) (1998) 555–570. [62] D.P. Shoemaker, C.W. Garland, Experiments in Physical Chemistry, fifth ed. McGraw-Hill International Edition, New York (1989). [63] (a) A.A. A. Emara, Spectrochm Acta A 77 (2010) 117- 125.; (b) Z.H. Abd ElWahab, M.R. El-Sarrag, Spectrochim Acta A 60 (2004) 271. [64] M.M. Deshpande, S.B. Junne, D.V. Saraf and P.A. Kulkarni, J. Chem. Pharm. Res.,"
    }, {
      "heading" : "2010, 2 (3):453-458.",
      "text" : "[65] A.K. S. Gupta and V.D. Barhate, Res. J. Pharm. Biol. Chem. Sci.,3 (2012) 1013. [66] M. Hazra, S. K. Dey, T. Dolai, and A. Patra, A. Pandey, Bioinorg. Chem. Appl. 2014 (2014) 13. [67] R. K. Parashar, R. C. Sharma, Inorg. Chim. Acta, 151 (1988) 201-208. [68] O. A.M. Ali, S. M. El-Medani, M.R. Abu Serea, A.S.S. Sayed, Spectrochim Acta A"
    }, {
      "heading" : "136 (2015) 651–660.",
      "text" : "[69] M. Asadi, Z. Asadi, N. Savaripoor, M. Dusek, V. Eigner, M.R. Shorkaei, M. Sedaghat, Spectrochim Acta A 136 (2015) 625–634. [70] R. Kaushal and S. Thakur, Chemical Engineering Transactions, 32 (2013)1801– 1806. [71] S. Knoblauch, R. Benedix, M. Ecke, T. Gelbrich, J. Sieler, F. Somoza, H. Hennig, Eur. J. Inorg. Chem. 8 (1999) 1393–1403. [72] E. Canpolat, and M. Kaya, J. Coord. Chem., 57, 14 (2004) 1217–1223. [73] (a) F.A. Cotton, G. Wilkinson, C.A. Murillo, M. Bochmann, Advanced Inorganic Chemistry, sixth ed., Wiley, New York, 1999; (b) A. Hazell, C.J. McKenzie, L.P. Nielsen, Polyhedron 19 (2000)1333. [74] (a) A.A. El-Asmy, T.Y. Al-Ansi, R.R. Amine, M.M. Mounir, Polyhedron 9 (1990) 2029.; (b) S.M. Jadavy, V.A. Shelkey, A.S. Mundez, S.G. Shankarwaey, V. R. Patharkary, and T.K. Chondhekar, J. Coord. Chem., 63, 23(2010) 4153–4164.\nAC C\nEP TE\nD M\nAN U\nSC R\nIP T"
    }, {
      "heading" : "ACCEPTED MANUSCRIPT",
      "text" : "[75] A.A. A. Emara, F.S. M. Abd El-Hameed, S.M. E. Khalil, Phosphorus, Sulfur and Silicon 114 (1996) 1. [76] (a) P.B. Maravalli, T.R. Goudar, , Thermochimica Acta 325(1999) 35.; (b) S.S. Kandil, B.G. El-Hefnawy, A.E. Baker, Thermochimica Acta 414(2009)105.; (c) T.A. Yousef, G.M. Abu El-Reash, I.M. Gabr, O.A. El-Gammal, R.A. Bedier, J. Mol. Struct., 1029 (2012) 149. [77] O.A. El-Gammal, Inorg. Chim. Acta 435 (2015) 73–81.\n[78] S. Rajalakshmi, T. Weyhermüller, A.J. Freddy, H.R. Vasanthi, B.U. Nair, Eur. J.Med. Chem. 46 (2011) 608–617. [79] (a) C. N. N’soukpoe Kossi, C. Descoteaux, E. Asselin, H. A. T. Riahi, G. Berube, Cell Biol. 27 (2008) 101-107.; (b) M.J. Waring, J. Mol. Biol. 13 (1965) 269-282.; (c) V. Muniyandi, N. Pravin, N. Raman, Inorg. Chem. Commun., 46 (2014) 60–64. [80] D.L. Arockiasamy, S. Radhika, R. Parthasarathi, B.U. Nair, J. Med. Chem. 44 (2009) 2044-2051. [81] A. Verma and F. Stellacci, Small 6, 1(2010) 12–21. [82] J.A. Champion and S. Mitragotri, Proceedings of the National Academy of Sciences of the United States of America, 103, 13 (2006) 4930–4934. [83] (a) Y.J. Liu, Z.Z. Li, Z.H. Liang, J.H. Yao, H.L. Huang, DNA Cell Biol 30: (2011) 839-848.;(b) J.Z. Lu, Y.F. Du, H.W. Guo, J. Jiang, X.D. Zeng, et al., J. Coord. Chem., 64: (2011) 1229-1239. [84] G. Eisenbrand, B. Pool-Zobel, V. Baker, M. Balls, B.J. Blaauboer, A. Boobis, A. Carere, S. Kevekordes, J.C. Lhuguenot, R. Pieters, J. Kleiner, Food Chem. Toxicol. 40 (2002) 193–236. [85] (a) T. Mosmann, J. Immunol. Methods 65 (1983) 55–63.; (b) Y. Liu, D.A. Petersen, H. Kimura, D. Schubert,, J. Neuro. Chem., 69 (1997) 581-593.; (c) E. Ulukaya, F. Ozdikicioglu, A.Y. Oral, M. Demirci, Toxicol in Vitro, 22 (2008) 232-239. [86] H. Shamsuzzaman, A. Khan Am, A. Mashrei, Sherwani, M. Owais, N. Siddiqui, Steroids 78 (2013) 1263. [87] B. Biersack, R. Schobert, Curr. Drug. Targets, 13 (2012) 1705-1719. [88] K.W. Powers, M. Palazuelos, B.M. Moudgil and S.M. Roberts, Nanotoxicology, 1, no. 1(2007) 42–51, 2007 [89] V.A. Shelke, S.M. Jadhav, V.R. Patharkar, S.G. Shankarwar, A. S. Munde, and T. K. Chondhekar, Arabian J. Chem., 5, 4(2012) 501–507. [90] B. G. Tweedy, Phytopathology, 55 (1964) 910–914.\nAC C\nEP TE\nD M\nAN U\nSC R\nIP T"
    }, {
      "heading" : "ACCEPTED MANUSCRIPT",
      "text" : "[91] T. D. Thangadurai and K. Natarajan, Transit. Met. Chem. vol. 26, no. 4-5, (2001) 500–504.\nAC C\nEP TE\nD M\nAN U\nSC R\nIP T\nACCEPTED MANUSCRIPT\nScheme Captions\nScheme 1: Synthesis of npap ligand. Scheme 2: Suggested structure of metal complexes.\nAC C\nEP TE\nD M\nAN U\nSC R\nIP T\nACCEPTED MANUSCRIPT\nOH\nreflux, 1h 70 oC\nN\nNH2 CHO\nScheme 1: Synthesis of npap ligand.\nAC C\nEP TE\nD M\nAN U\nSC R\nIP T\nACCEPTED MANUSCRIPT\nN (E)\nN\nFe\nO N\n(E)\nN\nO\n2H2O .\nO\nN\nN\n1/2H2O.\nCr\nCl\nOH2\nCl\nO\nN N\nCo\nONO2\n. 1/2 H2O\nO\nN N\nNi\nONO2\n. 2H2O\nScheme 2: Suggested structure of metal complexes, where a, b, c, d are npapFe, npapCr, npapCu\nand npapNi respectively.\n(a) (b)\n(c) (d)\nAC C\nEP TE\nD M\nAN U\nSC R\nIP T\nACCEPTED MANUSCRIPT\n35\nTable Captions\nTable 1(a) Crystal data and structure refinements details for npap ligand. Table 1(b) Selected bond lengths (x, y, z) and bond angles ( o ) of npap ligand.\nTable 2 Elemental and physical data of Schiff base ligand (npap) and its metal(II) complexes.\nTable 3 Electronic absorption spectral data (in DMF) of the Schiff base ligand and its metal(II) complexes.\nTable 4 The formation constant (Kf), stability constant (pK) and Gibbs free energy∆(G * ) values of the synthesized complexes at 298K.\nTable 5 Thermal decomposition steps, mass loss (%), proposed lost segments, final residue thermo-kinetic activation parameters of each decomposition step for metal\ncomplexes.\nTable 6 Spectral parameters for DNA interaction with the synthesized complexes. Table 7 Cytotoxicity and antiviral activity of the test compounds against HSV. Table 8 Screening of antiviral activity against Tobacco Mosiac Virus (TMV). Table 9 Minimum inhibition concentration (MIC) for antimicrobial assay of the prepared compounds.\nTable 10 Results of activity index (%) for antimicrobial assay of the prepared compounds. .\nACCEPTED MANUSCRIPT\nACCEPTED MANUSCRIPT\nAC C\nEP TE\nD M\nAN U\nSC R\nIP T\nACCEPTED MANUSCRIPT\nTable. 2: Elemental and physical data of Schiff base ligand (npap) and its metal(II) complexes.\nCompound\nEmpirical\nFormula\nColor\nYield\nElemental analysis\nFound (Calc.) %\nΛM\n(Ω –1 mol –\n1\nformula weight (%)\nμeff\nC\nH\nN\ncm 2 )\nnpap C16H12 N2O 248 yellow 80 --- 77.35 4.79 11.25 ---\n(77.42) (4.84) (11.25)\nnpapCr Cr[C16H13N2O2Cl]. 0.5H2O 397 Dark green 77 3.84 48.21 3.50 6.09 7.42\n(48.37) (3.53) (7.06)\nnpapFe Fe[C 32 H 22 N 4 O 4]. 2H2O 585.56 Dark brown 86 4.95 65.35 4.39 9.49 4.70\n(65.42) (4.44) (9.56)\nnpapCo Co[C 16 H 11 N 3 O 4]. 0.5 H2O 376.93 Orange 87 4.33 50.85 3.11 11.08 3.21\n(50.90) (3.18) (11.14)\nnpapNi Ni[C 16 H 11 N 3 O 4]. 2H2O 403.69 Bright green 84 2.74 47.56 3.63 10.34 6.72\n(47.57) (3.72) (10.40)\nAC C\nEP TE\nD M\nAN U\nSC R\nIP T\nACCEPTED MANUSCRIPT\nTable 3. Uv/Vis spectral data (nm) for npap and its metal complexes in DMF at 298 K.\nTable 4. The formation constant (Kf), stability constant (pK) and Gibbs free energy∆(G * ) values of the synthesized complexes at 298 K.\nComplex Type of complex Kf logKf G *\n(KJ mol -1 )\nnpapCr 1:1 5.53 ± 0.02 × 10 5 5.74 - 32.76 npapFe a* 1:2 1.79 ± 0.02 × 10 10 10.25 - 58.49 npapCo 1:1 1.42 ± 0.02 × 10 5 5.15 - 29.40\nnpapNi 1:1 5.38 ± 0.02 × 10 5 5.73 - 32.96\nCompounds λmax (nm) εmax\n(dm 3 mol -1 cm 1 )\nAssignment\nnpap 391\n427\n1411 1252\n*n *n\nnpapCr 390 1614 Intraligand band\n442 1401 LCMT band\n567 388 d-d band\nnpapFe 398 1539 Intraligand band\n480 1642 LCMT band 586 1319 d-d band\nnpapCo 236\n403 525 678\n622 485 233 224\nIntraligand band\nLCMT band LCMT band\nd-d band\nnpapNi 390\n454 640\n634 526 274\nIntraligand band\nLCMT band\nd-d band\nAC C\nEP TE\nD M\nAN U\nSC R\nIP T\nACCEPTED MANUSCRIPT\nTable 5. Thermal decomposition steps, mass loss (%), proposed lost segments, final residue thermo-kinetic activation parameters of each decomposition step for metal complexes.\nComplex Decomp.\nTemp.\n( o C)\nMass loss (%) proposed\nsegment\nE *\n(KJ. mol -1 )\nA (S -1 ) ×10 4\n∆H *\n(KJmol -1 )\n∆G *\n(KJmol -1 )\n∆S * (Jmol -1 K -1\n) Found (Calc.)\nnpapCr 27- 110 o C\n2.25\n(2.27)\n0.5H2O 0.12 0.79\n- 0.48 10.41 - 155.76\n110- 210 o C\n4.48\n(4.53)\nH2O\n- 1.58 35.72 - 164.83\n210- 391 o C\n8.93\n(8.95)\nCl -\n- 2.75 59.37 - 169.21\n391- 478 o C\n19.60 (19.65) C5H4N\n- 3.66 75.49 - 171.49\n478- 749 o C\n51.40\n(51.51)\nC11H7NO,\nCl -\n- 5.00 103.64 - 174.01\nResidue > 749 oC\n13.34 (13.09) Cr - - - - -\nnpapFe 15 -135 o C 6.17 (6.14) 2H2O 0.10 1.25 - 0.81 16.44 - 158.16\n135- 394 o C 33.40 (33.29) C12H7N2O - 2.06 40.91 - 165.39\n394- 581 o C 51.06 (51.02) C20H15N2O - 2.75 54.72 - 167.6\nResidue > 581 o C 9.37 (9.53) Fe - - - - -\nnpapCo 15- 110 o C 2.31\n(2.39)\n0.5H2O 0.11 0.27\n- 0.39 9.56 - 165.84\n110- 241 o C 8.08 (7.96) NO\n- 1.06 23.29 - 172.93\n241- 399 o C\n41.82 (41.92)\nC10H6O2\n- 2.47 53.25 - 179.50\n399- 567 o C\n32.04 (32.10)\nC6H5N2O\n- 3.75 81.19 - 182.85\nResidue > 567 oC 15.74 (15.64) Co - - -\nnpapNi 16-115 o C 8.89 (8.92) 2H2O 0.11 0.29\n- 1.05 20.45 - 150.00\n116- 222 o C 7.38 (7.43) NO\n- 1.54 26.04 - 160.00\n223- 381 o C 30.65\n(30.72)\nC5H4N2O2 - 2.23 46.27 - 170.00\n384- 595 o C 38.39 (38.40)\nC11H7O - 2.80 53.51 - 180.00\nResidue > 595 oC 14.69 (14.53) Ni - - -\nAC C\nEP\nTE\nD M\nAN U\nSC R\nIP T\nACCEPTED MANUSCRIPT\nTable 6. Intrinsic binding constant (Kb) values of Schiff base metal(II) complexes\nCompound\nλmax (nm) Δn\n(nm)\na H%\nb\nK b × 10\n6\n(M -1 )\nΔG*\n(KJ.mol -1 ) free bound\nnpapCr 313 346 33 37.89 0.086 - 28.15\n368 383 6 34.20 555 562 7 37.31\nnpapFe 414 443 29 55.44 1.740 - 35.61\n648 655 7 58.34\nnpapCo 241 242 1 21.29 0.024 - 26.43\n366 365 1 41.10 585 586 1 72.04\nnpapNi 239 238 1 9.20 0.230 - 30.53\n402 355 47 35.11\na H% = [(Afree-Abound)/Afree] x 100% b\nKb = Intrinsic DNA binding constant determined from the UV–Vis absorption spectral titration\nTable 7: Cytotoxicity and antiviral activity of the test compounds against HSV virus.\nCompounds Minimum cytotoxic\nconcentration (µg/ml) 1\nMinimum inhibitory concentration (IC50) 2\nHerpes simplex\nvirus-1 (KOS)\nHerpes simplex\nvirus2- (G)\nHerpes simplex virus-1\nTK-VMW1837\nnpapCr 87 126.4 0.03 33.8 npapFe 60 12.3 38.9 20.8\nnpapCo 70 14.6 116.8 > 400 npapNi 110 38.3 20.1 14.2\nBVDU > 400 0.0256 > 400 0.64\nACG > 400 0.0768 0.0768 0.64 DHPG > 100 0.0038 0.0064 0.32\n1Concentration required to cause a microscopically detectable alteration of normal cell morphology 2Concentration required to reduce virus-induced cytopathogenicity by 50 %.\nAC\nC\nEP TE\nD M\nAN U\nSC R\nIP T\nACCEPTED MANUSCRIPT\nTable 8. Screening of antiviral activity against Tobacco Mosaic Virus (TMV).\nCompounds Minimum inhibitory concentration\nnpapCr 70.4 npapFe 0.84 npapCo 1.34 npapNi 18.4\nTable 9. Minimum inhibition concentration (MIC) for antimicrobial assay of the prepared compounds\np. aeruginosa= pseudomonas aeruginosa, E. coli= Escherichia coli, S. aureus = Staphylococcus aureus, A. flavus = Aspergillus\nflavus, C. albicans = Candida albicans, T. rubrum = Trichophyton rubum.\nTable 10. Results of activity index (%) for antimicrobial assay of the prepared compounds.\nCompounds\nActivity index (%)\nBacteria\nP .aeruginosa E. coli S. aureus\nFungi\nA. flavus C. albicans T. rubrum\nnpap 28.57 27.59 27.59 47.37 36.67 28.57 npapFe 60.00 65.52 74.36 73.68 83.33 76.92 npapCr 77.14 72.41 72.41 84.21 80.77 80.77 npapCo 57.14 62.07 62.07 78.95 73.08 73.08 npapNi 71.43 62.07 62.07 78.95 84.62 84.62\np. aeruginosa= pseudomonas aeruginosa, E. coli= Escherichia coli, S. aureus = Staphylococcus aureus, A. flavus = Aspergillus\nflavus, C. albicans = Candida albicans, T. rubrum = Trichophyton rubum.\ncompounds\nBacteria\nP. aeruginosa E. coli S. aureus\nFungi\nA. flavus C. albicans T. rubrum\nnpap 9 8 8 9 7 9 npapFe 3 5 5 5 3 4 npapCr 2 4 4 3 5 4 npapCo 4 5 6 5 6 6 npapNi 5 4 5 4 3 6\nAC C\nEP TE\nD M\nAN U\nSC\nR\nIP\nT\nACCEPTED MANUSCRIPT\nFigure Captions\nFig. 1. (a) An ORTEP drawing of the npap Schiff base ligand with the atom- numbering scheme.; (b) Molecular packing and hydrogen bonding interactions of npap ligand.\nFig. 2. Molecular electronic spectra of (1) [npap] = (2) [npapCr] = (3) [npapFe] = 10 -3 mol dm -3 ,\n(4) [npapCo] = (5) [npapNi] = 2 × 10 -3 mol dm -3 .\nFig.3. Continuous variation plots for the prepared complexes in aqueous –ethanolic (1: 1) medium\nat [npapNi] = [npapCr] = [npapCo] = [npapFe]= 10 -3 mol dm -3 and 298 K.\nFig. 4. Molar ratio plots for the studied complexes in aqueous–ethanolic mixture at [M] = [Fe] =\n[Cr] = [Co] = [Ni] = 10 -3 mol dm -3 , [npap] = 10 -3 mol dm -3 at 298 K.\nFig. 5. pH-profile of the prepared complexes at [complex] = 10 -3 M. Fig. 6. Cyclic voltammograms of 10 -5 mol dm -3 of each complex at 50 mVs -1 in 0.2 M PBS at glassy carbon electrode (3 mm), where (a) npapCr (b) npapCo (c) npapFe at different scan rates (10, 20, 30 mVs -1 ).\nFig. 7. TEM images and calculated histogram of metal complexes. Fig. 8. (a) Spectrophotometeric titration of npapFe complex (10 -4 M) in 0.01 M Tris buffer (pH 7.4, 25 o C) with CT-DNA form 3µM to 30µM, The arrow indicates upon increasing the amount of DNA. (b) Plot of [CTDNA] / (εa-εb ) vs. [CT-DNA] for the titration of CT-\nDNA with npapFe complex.\nFig. 9. The effect of increasing the amount of the synthesized complexes on the relative viscosities of DNA at [DNA] = 0.5 mM, [complex] and [EB] = 25–250µM at 298 K.\nFig. 10. Gel electrophoresis pattern showing the interaction of the investigated complexes with DNA where Lane 1: CT-DNA+ npapFe, Lane 2: CT DNA + npapCr, Lane 3: CT-DNA+ npapCo, Lane 4: CT-DNA+ npapNi; Lane 5: blank, Lane 6: CT-DNA alone.\nFig. 11. Radical Scavenging Activity of three synthesized compounds using ABTS radical.\nFig. 12. Histogram showing the comparative antibacterial activities of the prepared compounds against different strains of bacteria (P. aeruginosa, E. coli and S. aureus) at 10 and\n25 mg/ml.\nFig. 13. Histogram showing the comparative antifungal activities of the compounds against different strains of fungi (A. flavus, C. albicans, T. rubrum) at 10 and 25 mg /ml.\nAC C\nEP TE\nD M\nAN\nU\nSC\nR\nIP T\nACCEPTED MANUSCRIPT\nFig. 1. (a) An ORTEP drawing of the npap Schiff base ligand with the atom- numbering scheme.\nAC C\nEP\nTE\nD\nACCEPTED MANUSCRIPT\n2 × 10 -3 mol dm -3 in DMF at 298 K.\nFig.3. Continuous variation plots for the prepared complexes in\naqueous –ethanolic medium at [npapNi] = [npapCr] =\n[npapCo] = [npapFe]= 10 -3 mol dm -3 and 298 K.\nAC C\nEP\nTE\nD\nACCEPTED MANUSCRIPT\nmol dm -3 , [npap]= 10 -3 mol dm -3 at 298 K.\nFig. 5. pH-profile of the prepared complexes at [complex] =\n10 -3 mol dm -3 .\nAC C\nEP TE\nD M\nAN U\nSC R\nIP T\nACCEPTED MANUSCRIPT\nAC C\nEP TE\nD M\nAN U\nSC R\nIP T\nACCEPTED MANUSCRIPT\nFig. 7: TEM images and calculated histogram for metal complexes (a) npapCr, (b) npapFe, (c) npapCo and (d) npapNi respectively.\na\nb\nc d\nM\nAN\nACCEPTED MANUSCRIPT\nAC C\nEP\nTE\nD\nACCEPTED MANUSCRIPT\nnpapCo, Lane 4: CT-DNA+ npapNi; Lane 5: blank, Lane 6: CT-DNA alone.\nAC C\nEP TE\nD M\nAN U\nSC R\nIP T\nACCEPTED MANUSCRIPT\nFig. 12. Histogram showing the comparative antibacterial activities of the prepared compounds against different strains of bacteria (P. aeruginosa, E. coli and\nS. aureus) at 10 and 25 mg /ml.\nFig. 13. Histogram showing the comparative antifungal activities of the compounds against different strains of fungi (A. flavus, C. albicans, T. rubrum) at 10 mg /ml.\nAC C\nEP TE\nD M\nAN U\nSC R\nIP T\nACCEPTED MANUSCRIPT\nGraphical abstract\nAC C\nEP TE\nD M\nAN U\nSC R\nIP T\nACCEPTED MANUSCRIPT\nHighlights\nSome nano-sized complexes were synthesized and characterized via different techniques.\n The redox behavior of the prepared complexes was investigated using cyclic\nvoltammetry.\n Interaction of the prepared nanosized complexes with CT-DNA was estimated by\ndifferent routes.\n Investigation of antioxidant activity of the prepared nanosized complexes was done\nby ABTS assay.\n Cytotoxic and antiviral activities of the nanosized complexes were checked against\nsome viruses.\n Antimicrobial activities were screened against different types of organisms."
    } ],
    "references" : [ {
      "title" : "Transition Met",
      "author" : [ "N.K. Singh", "A. Srivastava", "A. Sodhi", "P. Ranjan" ],
      "venue" : "Chem., 25, 2 ",
      "citeRegEx" : "1",
      "shortCiteRegEx" : null,
      "year" : 2000
    }, {
      "title" : "J",
      "author" : [ "L.H. Abdel-Rahman", "R.M. El-Khatib", "L.A.E. Nassr", "A.M. Abu- Dief" ],
      "venue" : "Mole. Struct. 1040, ",
      "citeRegEx" : "2",
      "shortCiteRegEx" : null,
      "year" : 2013
    }, {
      "title" : "J",
      "author" : [ "L.H. Abdel-Rahman", "R.M. El-Khatib", "L.A.E. Nassr", "A.M. Abu-Dief", "M. Ismael" ],
      "venue" : "Spectrochim Acta Part A117 ",
      "citeRegEx" : "3",
      "shortCiteRegEx" : null,
      "year" : 2013
    }, {
      "title" : "Int",
      "author" : [ "L.H. Abdel-Rahman", "A.M. Abu-Dief", "S.K. Hamdan", "A.A. Seleem" ],
      "venue" : "J. Nano. Chem. 1, No. 2, ",
      "citeRegEx" : "5",
      "shortCiteRegEx" : null,
      "year" : 2015
    }, {
      "title" : "A",
      "author" : [ "J. Garcia-Tojal" ],
      "venue" : "Garc ́ıa-Orad, A. A. D ́ıaz et al., J. Inorg. Biochem., 84, 3- 4, ",
      "citeRegEx" : "6",
      "shortCiteRegEx" : null,
      "year" : 2001
    }, {
      "title" : "Chem",
      "author" : [ "P.R. Reddy", "A. Shilpa" ],
      "venue" : "Biodivers., 9, no. 10, ",
      "citeRegEx" : "7",
      "shortCiteRegEx" : null,
      "year" : 2012
    }, {
      "title" : "J",
      "author" : [ "S.A. Patil", "S.N. Unki", "A.D. Kulkarni", "V.H. Naik", "P.S. Badami" ],
      "venue" : "Mole. Struct., 985, 2-3, ",
      "citeRegEx" : "8",
      "shortCiteRegEx" : null,
      "year" : 2011
    }, {
      "title" : "Photobiol",
      "author" : [ "F. Arjmand", "F. Sayeed", "M. Muddassir", "J. Photochem" ],
      "venue" : "B Biol., 103, 2 ",
      "citeRegEx" : "9",
      "shortCiteRegEx" : null,
      "year" : 2011
    }, {
      "title" : "Spectrochim",
      "author" : [ "C.N. Sudhamani", "H.S.B. Naik", "T.R.R. Naik", "M.C. Prabhakara" ],
      "venue" : "Acta A72, 3 ",
      "citeRegEx" : "10",
      "shortCiteRegEx" : null,
      "year" : 2009
    }, {
      "title" : "Chem",
      "author" : [ "H.F. Ji", "H.Y. Zhang" ],
      "venue" : "Res. Toxicol. 17 ",
      "citeRegEx" : "11",
      "shortCiteRegEx" : null,
      "year" : 2004
    }, {
      "title" : "Di Chen",
      "author" : [ "S. Adsule", "V. Barve" ],
      "venue" : "F. Ahmed, Q.P. Dou, S. Padhye, F.H. Sarkar, J. Med. Chem. 49 ",
      "citeRegEx" : "12",
      "shortCiteRegEx" : null,
      "year" : 2006
    }, {
      "title" : "Ann",
      "author" : [ "D.R. Alvira", "L.G. Navarro", "M.A. Gotor Lazaro", "E.R. Collado" ],
      "venue" : "Med. Int., 12 ",
      "citeRegEx" : "13",
      "shortCiteRegEx" : null,
      "year" : 1995
    }, {
      "title" : "G",
      "author" : [ "K. Olson", "P. Macias", "S. Hutton", "W.A. Ernst" ],
      "venue" : "Fujii, J.P. Adler-Moore, Vaccine 28 ",
      "citeRegEx" : "14",
      "shortCiteRegEx" : null,
      "year" : 2009
    }, {
      "title" : "S",
      "author" : [ "M.P. Nicoll", "J.T. Proenca" ],
      "venue" : "Efstathiou, FEMS Microbiol Rev., 36: ",
      "citeRegEx" : "15",
      "shortCiteRegEx" : null,
      "year" : 2012
    }, {
      "title" : "Eur",
      "author" : [ "B.S. Holla", "B. Veerendra", "M.K. Shivananda", "B. Poojary" ],
      "venue" : "J. Med. Chem., 38 ",
      "citeRegEx" : "16",
      "shortCiteRegEx" : null,
      "year" : 2003
    }, {
      "title" : "Anal",
      "author" : [ "H.F. Abd El-Halim", "F.A. Nour El-Dien", "G.G. Mohamed", "N.A. Mohamed", "J. Therm" ],
      "venue" : "Calorim., 109 ",
      "citeRegEx" : "17",
      "shortCiteRegEx" : null,
      "year" : 2012
    }, {
      "title" : "Molecules",
      "author" : [ "A. Jarrahpour", "D. Khalili", "E. De Clercq", "C. Salmi", "J.M. Brunel" ],
      "venue" : "12 ",
      "citeRegEx" : "18",
      "shortCiteRegEx" : null,
      "year" : 2007
    }, {
      "title" : "Coord",
      "author" : [ "G.H. Clever", "M. Shionoya" ],
      "venue" : "Chem. Rev., 254 ",
      "citeRegEx" : "19",
      "shortCiteRegEx" : null,
      "year" : 2010
    }, {
      "title" : "Synth",
      "author" : [ "A.M. Shaker", "A.M. Awad", "L.A.E. Nassr" ],
      "venue" : "React. Inorg. Metal – Org. Chem. 33 (1) ",
      "citeRegEx" : "20",
      "shortCiteRegEx" : null,
      "year" : 2003
    }, {
      "title" : "Pharm",
      "author" : [ "E.V. Sekhar", "K.N. Jayaveera", "S. Srihari, J. Chem" ],
      "venue" : "Res., 4(12) ",
      "citeRegEx" : "21",
      "shortCiteRegEx" : null,
      "year" : 2012
    }, {
      "title" : "Hydrogen Ions",
      "author" : [ "H.T.S. Britton" ],
      "venue" : "fourth ed., Chapman and Hall, London, UK",
      "citeRegEx" : "22",
      "shortCiteRegEx" : null,
      "year" : 1952
    }, {
      "title" : "SHELXS86. Program for the solution of crystal structures",
      "author" : [ "G.M. Sheldrick" ],
      "venue" : "Univ. of Gottingen, Federal Republic of Germany",
      "citeRegEx" : "23",
      "shortCiteRegEx" : "23",
      "year" : 1986
    }, {
      "title" : "CAMERON, Chemical Crystallography Laboratory, OXFORD",
      "author" : [ "D.J. Watkin", "C.K. Prout", "L.J. Pearce" ],
      "venue" : "UK",
      "citeRegEx" : "25",
      "shortCiteRegEx" : "25",
      "year" : 1996
    }, {
      "title" : "J",
      "author" : [ "E. Canpolat", "M. Kaya" ],
      "venue" : "Coord. Chem., 55 ",
      "citeRegEx" : "27",
      "shortCiteRegEx" : null,
      "year" : 2002
    }, {
      "title" : "J",
      "author" : [ "A.S. El-Tabl", "F.A. EL-Saied", "A.N. Al-Hakimi" ],
      "venue" : "Coord. Chem., 61 (15) ",
      "citeRegEx" : "28",
      "shortCiteRegEx" : null,
      "year" : 2008
    }, {
      "title" : "M",
      "author" : [ "K. Mohammadi" ],
      "venue" : "Rastegari, Spectrochim Acta A 97 ",
      "citeRegEx" : "29",
      "shortCiteRegEx" : null,
      "year" : 2012
    }, {
      "title" : "Ann",
      "author" : [ "P. Job" ],
      "venue" : "Chim. 9 ",
      "citeRegEx" : "30",
      "shortCiteRegEx" : null,
      "year" : 1928
    }, {
      "title" : "Synth",
      "author" : [ "A.M. Shaker", "A.M. Awad", "L.A.E. Nassr" ],
      "venue" : "React. Inorg. Metal – Org. Chem., 33 (1) ",
      "citeRegEx" : "31",
      "shortCiteRegEx" : null,
      "year" : 2003
    }, {
      "title" : "I",
      "author" : [ "A.W. Coats" ],
      "venue" : "P. Redfern, Nature 20 ",
      "citeRegEx" : "32",
      "shortCiteRegEx" : null,
      "year" : 1964
    }, {
      "title" : "El-Wadoud",
      "author" : [ "R.M. Issa", "A.A. Hassanein", "I.M. El-Mehasse", "R.I. Abed" ],
      "venue" : "Spectrochim Acta A 65 ",
      "citeRegEx" : "33",
      "shortCiteRegEx" : null,
      "year" : 2006
    }, {
      "title" : "J",
      "author" : [ "J. Marmur" ],
      "venue" : "Mol. Biol, 3",
      "citeRegEx" : "34",
      "shortCiteRegEx" : null,
      "year" : 1961
    }, {
      "title" : "T",
      "author" : [ "A. Wolf", "G.H. Shimer" ],
      "venue" : "Meehan, Biochem., 26 ",
      "citeRegEx" : "36",
      "shortCiteRegEx" : null,
      "year" : 1987
    }, {
      "title" : "Inter",
      "author" : [ "D. Sabolová", "M. Kozurková", "T. Plichta", "Z. Ondrušová", "D. Hudecová", "M. Simkovic", "H. Paulíková", "A. Valent" ],
      "venue" : "J. Bio. Macromol., 48 ",
      "citeRegEx" : "37",
      "shortCiteRegEx" : null,
      "year" : 2011
    }, {
      "title" : "Chem",
      "author" : [ "M. Vujcic", "S. Tufegdzic", "Z. Vujcic", "M.J. Gašic", "D. Sladic", "J. Serb" ],
      "venue" : "Soc., 72 ",
      "citeRegEx" : "39",
      "shortCiteRegEx" : null,
      "year" : 2007
    }, {
      "title" : "A",
      "author" : [ "D. Villano", "M.S. Fernandez-Pachon" ],
      "venue" : "M.Troncoso & M. C. Garcia-Parrilla, Talanta 64 ",
      "citeRegEx" : "40",
      "shortCiteRegEx" : null,
      "year" : 2004
    }, {
      "title" : "Screen",
      "author" : [ "H. Mueller", "M.U. Kassack", "M. Wiese", "J. Biomol" ],
      "venue" : "9(6) ",
      "citeRegEx" : "41",
      "shortCiteRegEx" : null,
      "year" : 2004
    }, {
      "title" : "and Shivaraj",
      "author" : [ "V. Kumar Chityala", "K. Sathish Kumar", "R. Macha", "P. Tigulla" ],
      "venue" : "J. Bioinorg.Chem. Appl., 2014, ",
      "citeRegEx" : "42",
      "shortCiteRegEx" : null,
      "year" : 2014
    }, {
      "title" : "Int",
      "author" : [ "S. Gopalakrishnan", "R. Rajameena", "E. Vadivel" ],
      "venue" : "J. Pharmaceut. Sci. Drug Res. 4 (1) ",
      "citeRegEx" : "45",
      "shortCiteRegEx" : null,
      "year" : 2012
    }, {
      "title" : "Chem",
      "author" : [ "H. Ranganathan", "D. Ramaswamy", "T. Ramasami", "M. Santappa" ],
      "venue" : "Lett., ",
      "citeRegEx" : "46",
      "shortCiteRegEx" : null,
      "year" : 1979
    }, {
      "title" : "Rosan Zakaria",
      "author" : [ "A.A.M. Belal", "I.M. El-Deen", "N.Y. Farid" ],
      "venue" : "Moamen S. Refat, Spectrochim Acta A 149 ",
      "citeRegEx" : "47",
      "shortCiteRegEx" : null,
      "year" : 2015
    }, {
      "title" : "N",
      "author" : [ "S.K. Gupta", "C. Anjana" ],
      "venue" : "Sen, R.J. Butcher, , J. P. Jasinski, J. A. Golen, Polyhedron 89, ",
      "citeRegEx" : "48",
      "shortCiteRegEx" : null,
      "year" : 2015
    }, {
      "title" : "M",
      "author" : [ "T.M.A. Ismail", "A.A. Saleh" ],
      "venue" : "A. El Ghamry, Spectrochim Acta A 86 ",
      "citeRegEx" : "51",
      "shortCiteRegEx" : null,
      "year" : 2012
    }, {
      "title" : "H",
      "author" : [ "E.Q. Castro", "B. Bernes", "A.T. Benavides", "R. Contreras" ],
      "venue" : "Noth, Polyhedron 19 ",
      "citeRegEx" : "54",
      "shortCiteRegEx" : null,
      "year" : 2000
    }, {
      "title" : "Infrared and Raman spectra of Inorganic and coordination compounds",
      "author" : [ "K. Nakamoto" ],
      "venue" : "Fourth ed., Wiley, New York ",
      "citeRegEx" : "55",
      "shortCiteRegEx" : null,
      "year" : 1980
    }, {
      "title" : "Spectrochimi",
      "author" : [ "J.E. Kovacic" ],
      "venue" : "Acta Part A 23",
      "citeRegEx" : "57",
      "shortCiteRegEx" : null,
      "year" : 1967
    }, {
      "title" : "Infrared spectra of Inorganic and coordination compounds",
      "author" : [ "K. Nakamoto" ],
      "venue" : "Wiley, New York, ",
      "citeRegEx" : "59",
      "shortCiteRegEx" : null,
      "year" : 1970
    }, {
      "title" : "Inorg",
      "author" : [ "M.E. Hossain", "M.N. Alam", "J. Begum", "M.A. Akbar", "M. Nagimuddin", "F.E. Smith", "R.C. Hynes" ],
      "venue" : "Chim. Acta, 249 ",
      "citeRegEx" : "60",
      "shortCiteRegEx" : null,
      "year" : 1996
    }, {
      "title" : "Synth",
      "author" : [ "A.M. Abdel-Mawgoud" ],
      "venue" : "Inorg. Met. Org. Chem., 28 (4) ",
      "citeRegEx" : "61",
      "shortCiteRegEx" : null,
      "year" : 1998
    }, {
      "title" : "Experiments in Physical Chemistry",
      "author" : [ "D.P. Shoemaker", "C.W. Garland" ],
      "venue" : "fifth ed. McGraw-Hill International Edition, New York ",
      "citeRegEx" : "62",
      "shortCiteRegEx" : null,
      "year" : 1989
    }, {
      "title" : "Pharm",
      "author" : [ "M.M. Deshpande", "S.B. Junne", "D.V. Saraf", "P.A. Kulkarni", "J. Chem" ],
      "venue" : "Res.",
      "citeRegEx" : "64",
      "shortCiteRegEx" : null,
      "year" : 2010
    }, {
      "title" : "Res",
      "author" : [ "A.K.S. Gupta", "V.D. Barhate" ],
      "venue" : "J. Pharm. Biol. Chem. Sci.,3 ",
      "citeRegEx" : "65",
      "shortCiteRegEx" : null,
      "year" : 2012
    }, {
      "title" : "Bioinorg",
      "author" : [ "M. Hazra", "S.K. Dey", "T. Dolai", "A. Patra", "A. Pandey" ],
      "venue" : "Chem. Appl. 2014 ",
      "citeRegEx" : "66",
      "shortCiteRegEx" : null,
      "year" : 2014
    }, {
      "title" : "Inorg",
      "author" : [ "R.K. Parashar", "R.C. Sharma" ],
      "venue" : "Chim. Acta, 151 ",
      "citeRegEx" : "67",
      "shortCiteRegEx" : null,
      "year" : 1988
    }, {
      "title" : "S",
      "author" : [ "O.A.M. Ali" ],
      "venue" : "M. El-Medani, M.R. Abu Serea, A.S.S. Sayed, Spectrochim Acta A 136 ",
      "citeRegEx" : "68",
      "shortCiteRegEx" : null,
      "year" : 2015
    }, {
      "title" : "M",
      "author" : [ "M. Asadi", "Z. Asadi", "N. Savaripoor", "M. Dusek", "V. Eigner", "M.R. Shorkaei" ],
      "venue" : "Sedaghat, Spectrochim Acta A 136 ",
      "citeRegEx" : "69",
      "shortCiteRegEx" : null,
      "year" : 2015
    }, {
      "title" : "Chemical Engineering Transactions",
      "author" : [ "R. Kaushal", "S. Thakur" ],
      "venue" : "32 ",
      "citeRegEx" : "70",
      "shortCiteRegEx" : null,
      "year" : 2013
    }, {
      "title" : "Eur",
      "author" : [ "S. Knoblauch", "R. Benedix", "M. Ecke", "T. Gelbrich", "J. Sieler", "F. Somoza", "H. Hennig" ],
      "venue" : "J. Inorg. Chem. 8 ",
      "citeRegEx" : "71",
      "shortCiteRegEx" : null,
      "year" : 1999
    }, {
      "title" : "J",
      "author" : [ "E. Canpolat", "M. Kaya" ],
      "venue" : "Coord. Chem., 57, 14 ",
      "citeRegEx" : "72",
      "shortCiteRegEx" : null,
      "year" : 2004
    }, {
      "title" : "Advanced Inorganic Chemistry, sixth ed., Wiley",
      "author" : [ "F.A. Cotton", "G. Wilkinson", "C.A. Murillo", "M. Bochmann" ],
      "venue" : "New York,",
      "citeRegEx" : "73",
      "shortCiteRegEx" : "73",
      "year" : 1999
    }, {
      "title" : "4153–4164.  AC  C  EP  TE  D  M  AN  U  SC  R  IP  T  ACCEPTED MANUSCRIPT",
      "author" : [ "A.A. El-Asmy", "T.Y. Al-Ansi", "R.R. Amine", "M.M. Mounir" ],
      "venue" : "J. Coord. Chem.,",
      "citeRegEx" : "74",
      "shortCiteRegEx" : "74",
      "year" : 2010
    }, {
      "title" : "Phosphorus",
      "author" : [ "A.A.A. Emara", "F.S.M. Abd El-Hameed", "S.M.E. Khalil" ],
      "venue" : "Sulfur and Silicon 114 ",
      "citeRegEx" : "75",
      "shortCiteRegEx" : null,
      "year" : 1996
    }, {
      "title" : "Inorg",
      "author" : [ "O.A. El-Gammal" ],
      "venue" : "Chim. Acta 435 ",
      "citeRegEx" : "77",
      "shortCiteRegEx" : null,
      "year" : 2015
    }, {
      "title" : "Eur",
      "author" : [ "S. Rajalakshmi", "T. Weyhermüller", "A.J. Freddy", "H.R. Vasanthi", "B.U. Nair" ],
      "venue" : "J.Med. Chem. 46 ",
      "citeRegEx" : "78",
      "shortCiteRegEx" : null,
      "year" : 2011
    }, {
      "title" : "Chem",
      "author" : [ "D.L. Arockiasamy", "S. Radhika", "R. Parthasarathi", "B.U. Nair", "J. Med" ],
      "venue" : "44 ",
      "citeRegEx" : "80",
      "shortCiteRegEx" : null,
      "year" : 2009
    }, {
      "title" : "Small 6",
      "author" : [ "A. Verma", "F. Stellacci" ],
      "venue" : "1",
      "citeRegEx" : "81",
      "shortCiteRegEx" : null,
      "year" : 2010
    }, {
      "title" : "Proceedings of the National Academy of Sciences of the United States of America",
      "author" : [ "J.A. Champion", "S. Mitragotri" ],
      "venue" : "103, 13 ",
      "citeRegEx" : "82",
      "shortCiteRegEx" : null,
      "year" : 2006
    }, {
      "title" : "Food Chem",
      "author" : [ "G. Eisenbrand", "B. Pool-Zobel", "V. Baker", "M. Balls", "B.J. Blaauboer", "A. Boobis", "A. Carere", "S. Kevekordes", "J.C. Lhuguenot", "R. Pieters", "J. Kleiner" ],
      "venue" : "Toxicol. 40 ",
      "citeRegEx" : "84",
      "shortCiteRegEx" : null,
      "year" : 2002
    }, {
      "title" : "Sherwani",
      "author" : [ "H. Shamsuzzaman", "A. Khan Am", "A. Mashrei" ],
      "venue" : "M. Owais, N. Siddiqui, Steroids 78 ",
      "citeRegEx" : "86",
      "shortCiteRegEx" : null,
      "year" : 2013
    }, {
      "title" : "Curr",
      "author" : [ "B. Biersack", "R. Schobert" ],
      "venue" : "Drug. Targets, 13 ",
      "citeRegEx" : "87",
      "shortCiteRegEx" : null,
      "year" : 2012
    }, {
      "title" : "Nanotoxicology",
      "author" : [ "K.W. Powers", "M. Palazuelos", "B.M. Moudgil", "S.M. Roberts" ],
      "venue" : "1, no. 1",
      "citeRegEx" : "88",
      "shortCiteRegEx" : null,
      "year" : 2007
    }, {
      "title" : "Arabian J",
      "author" : [ "V.A. Shelke", "S.M. Jadhav", "V.R. Patharkar", "S.G. Shankarwar", "A.S. Munde", "T.K. Chondhekar" ],
      "venue" : "Chem., 5, 4",
      "citeRegEx" : "89",
      "shortCiteRegEx" : null,
      "year" : 2012
    }, {
      "title" : "Phytopathology",
      "author" : [ "B.G. Tweedy" ],
      "venue" : "55 ",
      "citeRegEx" : "90",
      "shortCiteRegEx" : null,
      "year" : 1964
    } ],
    "referenceMentions" : [ {
      "referenceID" : 0,
      "context" : "Introduction Metal complexes of oxygen and nitrogen containing Schiff bases have been the subject of current and growing interest because it possesses wide range of pharmacological activities [1-5].",
      "startOffset" : 192,
      "endOffset" : 197
    }, {
      "referenceID" : 1,
      "context" : "Introduction Metal complexes of oxygen and nitrogen containing Schiff bases have been the subject of current and growing interest because it possesses wide range of pharmacological activities [1-5].",
      "startOffset" : 192,
      "endOffset" : 197
    }, {
      "referenceID" : 2,
      "context" : "Introduction Metal complexes of oxygen and nitrogen containing Schiff bases have been the subject of current and growing interest because it possesses wide range of pharmacological activities [1-5].",
      "startOffset" : 192,
      "endOffset" : 197
    }, {
      "referenceID" : 3,
      "context" : "Introduction Metal complexes of oxygen and nitrogen containing Schiff bases have been the subject of current and growing interest because it possesses wide range of pharmacological activities [1-5].",
      "startOffset" : 192,
      "endOffset" : 197
    }, {
      "referenceID" : 4,
      "context" : "For example, pyridine derivatives, such as (aromatic) alkoxyl pyridine compounds, amino pyridine, and its derivatives, substituted fused pyridine compounds, have already been applied in widely the fields of agrochemical products [6].",
      "startOffset" : 229,
      "endOffset" : 232
    }, {
      "referenceID" : 5,
      "context" : "Moreover, pyridine derivatives play individual role in anthelminthic, bacteriocide, acaricide, and phytocide [7].",
      "startOffset" : 109,
      "endOffset" : 112
    }, {
      "referenceID" : 9,
      "context" : ") are also believed to be a connected with carcinogenesis, mutagenesis, arthritis, diabetes, inflammation, cancer, and genotoxicity due to the oxidative stress which appear as a result of imbalance between free radical generations [11, 12].",
      "startOffset" : 231,
      "endOffset" : 239
    }, {
      "referenceID" : 10,
      "context" : ") are also believed to be a connected with carcinogenesis, mutagenesis, arthritis, diabetes, inflammation, cancer, and genotoxicity due to the oxidative stress which appear as a result of imbalance between free radical generations [11, 12].",
      "startOffset" : 231,
      "endOffset" : 239
    }, {
      "referenceID" : 11,
      "context" : "Free oxygen radicals may protect against attack of the virus and can produce tissue damage during this protection by trig-gering inflammation [13].",
      "startOffset" : 142,
      "endOffset" : 146
    }, {
      "referenceID" : 12,
      "context" : "The virus infects Patients with immune deficiency and newborns [14].",
      "startOffset" : 63,
      "endOffset" : 67
    }, {
      "referenceID" : 13,
      "context" : "Reactivation of latent HSV, which is very prevalent during immunity deficiency, causes periodic herpetic infections [15].",
      "startOffset" : 116,
      "endOffset" : 120
    }, {
      "referenceID" : 14,
      "context" : "Some viral diseases, for example, rice tungro, African cassavamosaic, and tospoviruses, are evaluated to cause casualties losses in excess of AUD$1 billion worldwide [16].",
      "startOffset" : 166,
      "endOffset" : 170
    }, {
      "referenceID" : 1,
      "context" : "The resulting solutions were stirred magnetically for 3 h at 25 o C [2-5, 17, 18, 19].",
      "startOffset" : 68,
      "endOffset" : 85
    }, {
      "referenceID" : 2,
      "context" : "The resulting solutions were stirred magnetically for 3 h at 25 o C [2-5, 17, 18, 19].",
      "startOffset" : 68,
      "endOffset" : 85
    }, {
      "referenceID" : 3,
      "context" : "The resulting solutions were stirred magnetically for 3 h at 25 o C [2-5, 17, 18, 19].",
      "startOffset" : 68,
      "endOffset" : 85
    }, {
      "referenceID" : 15,
      "context" : "The resulting solutions were stirred magnetically for 3 h at 25 o C [2-5, 17, 18, 19].",
      "startOffset" : 68,
      "endOffset" : 85
    }, {
      "referenceID" : 16,
      "context" : "The resulting solutions were stirred magnetically for 3 h at 25 o C [2-5, 17, 18, 19].",
      "startOffset" : 68,
      "endOffset" : 85
    }, {
      "referenceID" : 17,
      "context" : "The resulting solutions were stirred magnetically for 3 h at 25 o C [2-5, 17, 18, 19].",
      "startOffset" : 68,
      "endOffset" : 85
    }, {
      "referenceID" : 18,
      "context" : "A few drops of glacial acetic acid [20] were added to obviate the oxidation of Fe(II).",
      "startOffset" : 35,
      "endOffset" : 39
    }, {
      "referenceID" : 1,
      "context" : "Then the obtained solid product was filtered, washed with ethanol, and then dried in vacuo over anhydrous CaCl2 [2-5, 21].",
      "startOffset" : 112,
      "endOffset" : 121
    }, {
      "referenceID" : 2,
      "context" : "Then the obtained solid product was filtered, washed with ethanol, and then dried in vacuo over anhydrous CaCl2 [2-5, 21].",
      "startOffset" : 112,
      "endOffset" : 121
    }, {
      "referenceID" : 3,
      "context" : "Then the obtained solid product was filtered, washed with ethanol, and then dried in vacuo over anhydrous CaCl2 [2-5, 21].",
      "startOffset" : 112,
      "endOffset" : 121
    }, {
      "referenceID" : 19,
      "context" : "Then the obtained solid product was filtered, washed with ethanol, and then dried in vacuo over anhydrous CaCl2 [2-5, 21].",
      "startOffset" : 112,
      "endOffset" : 121
    }, {
      "referenceID" : 20,
      "context" : "pH values were adjusted using a series of Britton universal buffer [22].",
      "startOffset" : 67,
      "endOffset" : 71
    }, {
      "referenceID" : 21,
      "context" : "The structure was solved by using the program(s): SHELXS86 [23]; program(s) used to refine structure: CRYSTALS [24].",
      "startOffset" : 59,
      "endOffset" : 63
    }, {
      "referenceID" : 22,
      "context" : "Molecular graphics: CAMERON [25]; software used to prepare material for publication.",
      "startOffset" : 28,
      "endOffset" : 32
    }, {
      "referenceID" : 1,
      "context" : "Magnetic susceptibility was calculated according to the following relation [2, 3, 4, 5, 26- 28]:",
      "startOffset" : 75,
      "endOffset" : 95
    }, {
      "referenceID" : 2,
      "context" : "Magnetic susceptibility was calculated according to the following relation [2, 3, 4, 5, 26- 28]:",
      "startOffset" : 75,
      "endOffset" : 95
    }, {
      "referenceID" : 3,
      "context" : "Magnetic susceptibility was calculated according to the following relation [2, 3, 4, 5, 26- 28]:",
      "startOffset" : 75,
      "endOffset" : 95
    }, {
      "referenceID" : 1,
      "context" : "Evaluation of the Stiochmetry of the Schiff base ligand complexes Continuous variation methods [2, 3] and molar ratio [4, 5] were used to study the equilibria in solutions and to determine M: L ratio as shown in Fig.",
      "startOffset" : 95,
      "endOffset" : 101
    }, {
      "referenceID" : 2,
      "context" : "Evaluation of the Stiochmetry of the Schiff base ligand complexes Continuous variation methods [2, 3] and molar ratio [4, 5] were used to study the equilibria in solutions and to determine M: L ratio as shown in Fig.",
      "startOffset" : 95,
      "endOffset" : 101
    }, {
      "referenceID" : 3,
      "context" : "Evaluation of the Stiochmetry of the Schiff base ligand complexes Continuous variation methods [2, 3] and molar ratio [4, 5] were used to study the equilibria in solutions and to determine M: L ratio as shown in Fig.",
      "startOffset" : 118,
      "endOffset" : 124
    }, {
      "referenceID" : 1,
      "context" : "The apparent formation constants (Kf) of the synthesized complexes formed in solution were determined from spectrophotometric measurements using the continuous variation method [2, 3, 4, 5, 29- 31], according to the following relations.",
      "startOffset" : 177,
      "endOffset" : 197
    }, {
      "referenceID" : 2,
      "context" : "The apparent formation constants (Kf) of the synthesized complexes formed in solution were determined from spectrophotometric measurements using the continuous variation method [2, 3, 4, 5, 29- 31], according to the following relations.",
      "startOffset" : 177,
      "endOffset" : 197
    }, {
      "referenceID" : 3,
      "context" : "The apparent formation constants (Kf) of the synthesized complexes formed in solution were determined from spectrophotometric measurements using the continuous variation method [2, 3, 4, 5, 29- 31], according to the following relations.",
      "startOffset" : 177,
      "endOffset" : 197
    }, {
      "referenceID" : 28,
      "context" : "(ΔS), enthalpy of activation (ΔH), and free energy change of the decomposition (ΔG * ) are estimated graphically from TGA data by employing the Coats–Redfern relation [32, 33] in the following form:",
      "startOffset" : 167,
      "endOffset" : 175
    }, {
      "referenceID" : 29,
      "context" : "(ΔS), enthalpy of activation (ΔH), and free energy change of the decomposition (ΔG * ) are estimated graphically from TGA data by employing the Coats–Redfern relation [32, 33] in the following form:",
      "startOffset" : 167,
      "endOffset" : 175
    }, {
      "referenceID" : 2,
      "context" : "9 : 1, indicating that DNA was free sufficiently form protein [3, 4, 34].",
      "startOffset" : 62,
      "endOffset" : 72
    }, {
      "referenceID" : 30,
      "context" : "9 : 1, indicating that DNA was free sufficiently form protein [3, 4, 34].",
      "startOffset" : 62,
      "endOffset" : 72
    }, {
      "referenceID" : 32,
      "context" : "calculated from the following relation [37].",
      "startOffset" : 39,
      "endOffset" : 43
    }, {
      "referenceID" : 1,
      "context" : "Data of measured viscosity was presented as (η/ ηo) 1/3 versus binding ratio R (R= [complex]/ [DNA] [2-5, 38], where η is the viscosity of DNA in the presence of complex and ηo that of DNA alone.",
      "startOffset" : 100,
      "endOffset" : 109
    }, {
      "referenceID" : 2,
      "context" : "Data of measured viscosity was presented as (η/ ηo) 1/3 versus binding ratio R (R= [complex]/ [DNA] [2-5, 38], where η is the viscosity of DNA in the presence of complex and ηo that of DNA alone.",
      "startOffset" : 100,
      "endOffset" : 109
    }, {
      "referenceID" : 3,
      "context" : "Data of measured viscosity was presented as (η/ ηo) 1/3 versus binding ratio R (R= [complex]/ [DNA] [2-5, 38], where η is the viscosity of DNA in the presence of complex and ηo that of DNA alone.",
      "startOffset" : 100,
      "endOffset" : 109
    }, {
      "referenceID" : 1,
      "context" : "5 μg/ml) ethidium bromide for 30 - 45 min at room temperature and later visualized under UV light using transilluminator and photographed with Panasonic DMC-LZ5 Lumix Digital camera [2-5, 39] and recorded in Fig .",
      "startOffset" : 182,
      "endOffset" : 191
    }, {
      "referenceID" : 2,
      "context" : "5 μg/ml) ethidium bromide for 30 - 45 min at room temperature and later visualized under UV light using transilluminator and photographed with Panasonic DMC-LZ5 Lumix Digital camera [2-5, 39] and recorded in Fig .",
      "startOffset" : 182,
      "endOffset" : 191
    }, {
      "referenceID" : 3,
      "context" : "5 μg/ml) ethidium bromide for 30 - 45 min at room temperature and later visualized under UV light using transilluminator and photographed with Panasonic DMC-LZ5 Lumix Digital camera [2-5, 39] and recorded in Fig .",
      "startOffset" : 182,
      "endOffset" : 191
    }, {
      "referenceID" : 33,
      "context" : "5 μg/ml) ethidium bromide for 30 - 45 min at room temperature and later visualized under UV light using transilluminator and photographed with Panasonic DMC-LZ5 Lumix Digital camera [2-5, 39] and recorded in Fig .",
      "startOffset" : 182,
      "endOffset" : 191
    }, {
      "referenceID" : 35,
      "context" : "were examined using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay as described previously [41, 42].",
      "startOffset" : 121,
      "endOffset" : 129
    }, {
      "referenceID" : 36,
      "context" : "were examined using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay as described previously [41, 42].",
      "startOffset" : 121,
      "endOffset" : 129
    }, {
      "referenceID" : 37,
      "context" : "Table 10) according to the following relation [45]:",
      "startOffset" : 46,
      "endOffset" : 50
    }, {
      "referenceID" : 40,
      "context" : "AC C EP TE D M AN U SC R IP T ACCEPTED MANUSCRIPT [48].",
      "startOffset" : 50,
      "endOffset" : 54
    }, {
      "referenceID" : 2,
      "context" : "and referred as paramagnetic character and suggested high spin values for octahedral geometry of iron (II) metal center [3].",
      "startOffset" : 120,
      "endOffset" : 123
    }, {
      "referenceID" : 41,
      "context" : "These values indicate that presence of two unpaired electrons in the d-orbital, therefore, the Formed nickel complex has tetrahedral geometry [51].",
      "startOffset" : 142,
      "endOffset" : 146
    }, {
      "referenceID" : 42,
      "context" : "On complexation, this band is shifted to the lower frequency range of 1568- 1577 cm -1 indicating coordination through pyridine nitrogen [54].",
      "startOffset" : 137,
      "endOffset" : 141
    }, {
      "referenceID" : 43,
      "context" : "Furthermore, from the spectroscopic behavior of simple metallic complexes of pyridine, it is known that after complexation the vibrations in the high frequency region are not appreciably shifted, whereas the ring deformation found at 604, 405 cm -1 in the free pyridine are shifted to higher frequencies [55].",
      "startOffset" : 304,
      "endOffset" : 308
    }, {
      "referenceID" : 44,
      "context" : "The characteristic phenolic υ(OH) mode due to the hydroxyl group of 2hydroxy-1-napthaldehyde moiety, present in the Schiff base ligand was observed at 3426 cm -1 [57].",
      "startOffset" : 162,
      "endOffset" : 166
    }, {
      "referenceID" : 45,
      "context" : "However, new bands in the region of 518-615 cm -1 and 453 - 482 cm -1 in the spectra of the metal complexes appeared and can be assigned to stretching frequencies of (M-O) and (M-N) bonds, respectively [59].",
      "startOffset" : 202,
      "endOffset" : 206
    }, {
      "referenceID" : 46,
      "context" : "Also, a weak broad band in the range 3434 - 3476 cm -1 was observed and it indicates to the presence of lattice water in the metal complexes [60].",
      "startOffset" : 141,
      "endOffset" : 145
    }, {
      "referenceID" : 47,
      "context" : "The other series of weak bands between 3000 -3064 cm -1 and can be attributed to ʋ (CH) aromatic stretching vibration [61].",
      "startOffset" : 118,
      "endOffset" : 122
    }, {
      "referenceID" : 48,
      "context" : "AC C EP TE D M AN U SC R IP T ACCEPTED MANUSCRIPT rocking mode of water [62].",
      "startOffset" : 72,
      "endOffset" : 76
    }, {
      "referenceID" : 49,
      "context" : "Schiff base ligand (npap) behaves as monobasic tridentate ligand and binds to the metal ions via the azomethine nitrogen, phenolic oxygen and pyridine nitrogen [64-67].",
      "startOffset" : 160,
      "endOffset" : 167
    }, {
      "referenceID" : 50,
      "context" : "Schiff base ligand (npap) behaves as monobasic tridentate ligand and binds to the metal ions via the azomethine nitrogen, phenolic oxygen and pyridine nitrogen [64-67].",
      "startOffset" : 160,
      "endOffset" : 167
    }, {
      "referenceID" : 51,
      "context" : "Schiff base ligand (npap) behaves as monobasic tridentate ligand and binds to the metal ions via the azomethine nitrogen, phenolic oxygen and pyridine nitrogen [64-67].",
      "startOffset" : 160,
      "endOffset" : 167
    }, {
      "referenceID" : 52,
      "context" : "Schiff base ligand (npap) behaves as monobasic tridentate ligand and binds to the metal ions via the azomethine nitrogen, phenolic oxygen and pyridine nitrogen [64-67].",
      "startOffset" : 160,
      "endOffset" : 167
    }, {
      "referenceID" : 54,
      "context" : "On complexation this band disappeared suggesting the coordination of azomethine nitrogen to the metal ion, as the formation of the metal– nitrogen bond stabilizes the electron pair on the nitrogen atom [69].",
      "startOffset" : 202,
      "endOffset" : 206
    }, {
      "referenceID" : 55,
      "context" : "Thus addition of metal ion to the ligand solution causes distinguishable changes in the visible absorption spectra of the ligand, suggesting an instantaneous complex formation in solution [70, 71].",
      "startOffset" : 188,
      "endOffset" : 196
    }, {
      "referenceID" : 56,
      "context" : "Thus addition of metal ion to the ligand solution causes distinguishable changes in the visible absorption spectra of the ligand, suggesting an instantaneous complex formation in solution [70, 71].",
      "startOffset" : 188,
      "endOffset" : 196
    }, {
      "referenceID" : 57,
      "context" : "This indicates tetrahedral geometry for the complex [72].",
      "startOffset" : 52,
      "endOffset" : 56
    }, {
      "referenceID" : 58,
      "context" : "to g g E T 5 5  , g g T E 2 2  transitions characteristic of octahedral geometry [73, 74].",
      "startOffset" : 83,
      "endOffset" : 91
    }, {
      "referenceID" : 59,
      "context" : "to g g E T 5 5  , g g T E 2 2  transitions characteristic of octahedral geometry [73, 74].",
      "startOffset" : 83,
      "endOffset" : 91
    }, {
      "referenceID" : 1,
      "context" : "The stoichiometry of the tested complexes was determined by applying the spectrophotometric continuous variation [4] and molar ratio methods [2].",
      "startOffset" : 141,
      "endOffset" : 144
    }, {
      "referenceID" : 60,
      "context" : "molecules within the complexes supports the elemental analyses [75].",
      "startOffset" : 63,
      "endOffset" : 67
    }, {
      "referenceID" : 28,
      "context" : "One of the major different methods were used to evaluate the kinetic thermodynamic parameters is the Coats–Redfern method [32].",
      "startOffset" : 122,
      "endOffset" : 126
    }, {
      "referenceID" : 28,
      "context" : "for the metal complexes using standard equation [32].",
      "startOffset" : 48,
      "endOffset" : 52
    }, {
      "referenceID" : 62,
      "context" : "On the other hand, hyperchromism results from the secondary damage of DNA double helix structure, in which the amplitude of hyperchromism is indicative of partial or nonintercalative binding modes [78].",
      "startOffset" : 197,
      "endOffset" : 201
    }, {
      "referenceID" : 63,
      "context" : "Basically, shape dependent nanotoxicity affects the membrane wrapping processes in vivo during endocytosis or phagocytosis [80].",
      "startOffset" : 123,
      "endOffset" : 127
    }, {
      "referenceID" : 64,
      "context" : "It has been observed that endocytosis of spherical nanoparticles is easier and faster as compared to rod shaped or fibre like nanoparticles [81].",
      "startOffset" : 140,
      "endOffset" : 144
    }, {
      "referenceID" : 1,
      "context" : "2 Viscosity studies Viscosity measurements are regarded as the least controversial and the most rigorous means of testing the binding mode of DNA in solution [2-5].",
      "startOffset" : 158,
      "endOffset" : 163
    }, {
      "referenceID" : 2,
      "context" : "2 Viscosity studies Viscosity measurements are regarded as the least controversial and the most rigorous means of testing the binding mode of DNA in solution [2-5].",
      "startOffset" : 158,
      "endOffset" : 163
    }, {
      "referenceID" : 3,
      "context" : "2 Viscosity studies Viscosity measurements are regarded as the least controversial and the most rigorous means of testing the binding mode of DNA in solution [2-5].",
      "startOffset" : 158,
      "endOffset" : 163
    }, {
      "referenceID" : 66,
      "context" : "The assessment of the cytotoxicity is usually performed by cell viability assays, such as the dye up take by non- viable cells or by alteration in cell functions [84].",
      "startOffset" : 162,
      "endOffset" : 166
    }, {
      "referenceID" : 67,
      "context" : "MTT assay is used to determine the cytotoxicity of the potential drugs and other toxic compounds [86].",
      "startOffset" : 97,
      "endOffset" : 101
    }, {
      "referenceID" : 68,
      "context" : " Effect of chelation: the significant activity of metal complexes in inhibiting ability, due to incorporation of metal ions increases the inhibition of cell growth [87].",
      "startOffset" : 165,
      "endOffset" : 169
    }, {
      "referenceID" : 69,
      "context" : "Seemingly, reducing the size of the materials leads to an exponential increase in surface area relative to volume, thereby making the nanomaterial surface more reactive on itself and to its contiguous milieu [88].",
      "startOffset" : 208,
      "endOffset" : 212
    }, {
      "referenceID" : 70,
      "context" : "12 it was observed that all investigated metal complexes are more efficient than the free ligand and such enhanced activity of metal chelates is due to the lipophilic nature of the metal ions in complexes [89].",
      "startOffset" : 205,
      "endOffset" : 209
    }, {
      "referenceID" : 71,
      "context" : "The higher biological activity of metal complexes than that of npap ligand can be explained on the basis of Overtone’s concept and Tweedy’s chelation theory [90].",
      "startOffset" : 157,
      "endOffset" : 161
    }, {
      "referenceID" : 71,
      "context" : "AC C EP TE D M AN U SC R IP T ACCEPTED MANUSCRIPT chelation theory [90].",
      "startOffset" : 67,
      "endOffset" : 71
    } ],
    "year" : 2016,
    "abstractText" : "To estimate the biological preference of synthetic small drugs towards DNA target, new metal based chemotherapeutic agents of nano-sized Cr(III), Fe(II), Co(II) and Ni(II) Schiff base complexes having N,N,O donor system were synthesized and thoroughly characterized by physic-chemical techniques. The redox behavior of the Cr(III), Fe(II) and Co(II) complex was investigated by electrochemical method using cyclic voltammetry. IR results proven that the tridentate binding of Schiff base ligand with metal center during complexation and reflects the proposed structure. Magnetic and spectroscopic data give support to octahedral geometry for Cr(III) and Fe(II) complexes and tetrahedral geometry for Ni(II) and Co(II) complexes. The activation thermodynamic parameters, such as, E * , ΔH * , ΔS * and ΔG * are calculated using Coats– Redfern method by analyzing the TGA data. The particle size of the investigated metal complexes was estimated by TEM. In addition to, the interaction of the nanosized metal complexes with CT-DNA was estimated by electronic absorption, viscosity and gel electrophoresis. These techniques revealed that the complexes could bind to CT-DNA through intercalation mode. Moreover, the in vitro cytotoxic and antiviral activities of the nanosized complexes were checked against Herpes Simplex virus and Tobacco Mosaic viruses. Moreover, investigation of antioxidant activities of the new nanosized compounds was done by ABTS assay. Among the compounds tested, Fe(II) complex showed the strongest potent radical scavenging activity with percent of 58.60 %. Furthermore, the antimicrobial bustle of the prepared compounds were screened different types of bacteria and fungi and the results show that all metal complexes have superior activity than free ligand.",
    "creator" : "Elsevier"
  }
}